Company Overview: Peel Hunt is a leading independent investment bank in the UK, known for its strong focus on mid and small-cap companies. With a rich history dating back to 1989, the company has established itself as a trusted advisor and broker, offering services like investment banking, research, trading, and asset management.

Financial Performance: Peel Hunt has demonstrated robust financial health over recent years. The company has shown consistent revenue growth, underpinned by a diversified income stream and a resilient business model. Its balance sheet remains strong, with a healthy liquidity position and a prudent approach to risk management.

Market Position and Competitive Advantage: Peel Hunt occupies a unique position in the market, specialising in mid and small-cap companies. This focus, combined with its comprehensive service offering, has enabled the firm to build deep client relationships and a strong reputation. The company's research capabilities and sector expertise are also key differentiators.

Growth Prospects: The future growth trajectory for Peel Hunt appears promising. The company is well-positioned to benefit from the increasing activity in the mid and small-cap market segments. Furthermore, its ongoing investment in technology and expansion of services are likely to open new revenue streams and enhance client engagement.

Risks and Challenges: Key risks include market volatility, regulatory changes, and increasing competition. However, Peel Hunt's adaptable business model and proactive risk management strategies position it well to navigate these challenges.

Investment Rationale: Based on Peel Hunt's strong market position, consistent financial performance, and clear growth strategy, it presents as a compelling investment opportunity. The company's specialised focus, combined with its robust operational framework, positions it to capitalise on market opportunities and deliver sustainable value to shareholders.

OperationsEdit

How did the idea behind the company come about?Edit

The idea behind Peel Hunt LLP originated from the desire to create a specialised, client-focused investment banking service. Founded in 1989 by Charles Peel and Christopher Holdsworth Hunt, the firm aimed to provide high-quality, independent advice and execution services to UK mid and small-cap companies. This focus on a specific market segment was somewhat unique at the time and set Peel Hunt apart from larger, more generalised investment banks. The firm's approach centered on building strong, lasting relationships with its clients, emphasising deep sector expertise, and providing tailored financial solutions. This dedication to serving a niche market effectively has been a defining characteristic of Peel Hunt since its inception.

What's the mission of the company?Edit

The mission of Peel Hunt LLP is focused on "guiding and nurturing people through the evolution of business"​​.[1] This mission statement highlights their commitment to supporting and advising their clients and stakeholders as the business landscape changes and evolves.

What's the company's flagship product and what makes it unique?Edit

Peel Hunt LLP, as an investment bank, doesn't offer a "flagship product" in the traditional sense like a tech or consumer goods company. Instead, their primary offerings are financial services, specifically tailored to the mid and small-cap sectors in the UK. What makes Peel Hunt unique is its specialised focus on these market segments, providing expert advice and services in equity research, sales, and trading, as well as corporate broking, advisory services, and investment banking. Their emphasis on in-depth sector knowledge, coupled with a strong commitment to independent, client-focused advice, differentiates them in the financial services industry. This approach allows them to cater effectively to a specific group of clients, creating strong, lasting relationships and a reputation for tailored, high-quality service.

What is the price of the main offering(s)?Edit

The pricing of Peel Hunt LLP's services, such as equity research, sales and trading, corporate broking, advisory services, and investment banking, is not typically publicly disclosed or standardised. These services are highly specialised and tailored to each client's needs, and as such, their pricing would vary depending on the complexity of the service, the scope of the engagement, the market segment, and other specific requirements of each client. Generally, in investment banking, fees can be structured as fixed amounts, percentages of the transaction value, or a combination of both, and are often negotiated on a case-by-case basis.

From which place(s) are the offerings able to be purchased?Edit

Peel Hunt LLP's financial services and offerings are primarily accessible from their offices in the United Kingdom. The firm operates predominantly within the UK market, focusing on serving UK mid and small-cap companies. Clients typically engage with Peel Hunt through their corporate offices for various services such as equity research, trading, corporate broking, advisory services, and investment banking. These services are usually procured through direct business-to-business interactions and are tailored to the specific needs of each client, rather than being available for purchase in a conventional retail sense.

From which place(s) are the offerings promoted?Edit

Peel Hunt LLP promotes its offerings primarily in the United Kingdom, reflecting its focus on the UK mid and small-cap markets. The firm leverages various channels for promotion, including its corporate website, industry events, financial news media, and professional networking opportunities. Additionally, as an investment bank, a significant portion of its promotion and client engagement likely occurs through direct, relationship-driven business development efforts, targeting specific sectors and companies that align with their expertise and service offerings.

What's the current strategy of the company?Edit

Peel Hunt LLP's current strategy, as outlined in their 2023 annual report and other sources, revolves around the following key priorities:

  1. Extending Leading Liquidity Provision: Peel Hunt has transformed from a market maker to a key liquidity provider, trading in over 5,000 UK securities and 9,800 overseas securities. They aim to continue this growth by adding incremental liquidity, expanding and diversifying trading counterparties, developing new digital infrastructure to live stream prices to alternative venues, and establishing new strategic partnerships with larger pan-European liquidity providers​​.
  2. Expanding Investment Banking Capabilities: Having evolved from a corporate broking business to a specialist UK investment bank, Peel Hunt is focusing on building its track record with mid-cap and growth companies. The firm is diversifying its client base to include both public companies and its Private Capital Markets business. Additionally, they're expanding services in areas like M&A and Debt Advisory, and integrating investment banking teams with Research & Distribution to deepen relationships with institutional investors​​.
  3. Advancing as a Distribution Powerhouse: Recognised for its award-winning research and experienced distribution teams, Peel Hunt is strengthening its role as a connector between investment institutions and companies. They are deepening relationships with institutional investors, expanding market share, and enhancing their international influence and access. Notably, they've invested in North American and European distribution platforms and are planning to establish a new European office in Copenhagen​​.
  4. Embedding Technology in Operations: Technology is central to Peel Hunt's business strategy. The firm is investing in and innovating digital tools and infrastructure to maintain competitive pricing and secure access to liquidity. A notable development is the spinning out of their proprietary REX platform into a standalone business, RetailBook, aimed at expanding retail participation in capital markets​​.
  5. Leveraging Unique Culture for Performance: Peel Hunt's collaborative culture is seen as a key strength, fostering team collaboration and an increased focus on performance. The firm encourages cross-functional projects and initiatives to drive strategic goals. A newly launched Investment Banking graduate program exemplifies their approach to harnessing internal talent and ideas​​.

These strategic priorities highlight Peel Hunt's focus on diversification, technology integration, and deepening client relationships, positioning them well for future growth despite challenging market conditions.

Who are the key members of the team and what makes them unique?Edit

Listed company boardEdit

Key members of Peel Hunt LLP's team, each bringing unique experiences and expertise, include:

  1. Lucinda Riches - Chair: Lucinda Riches is the Independent Non-Executive Chair of Peel Hunt. She has a distinguished career in investment banking, previously serving as Global Head of Equity Capital Markets at UBS. Her experience spans various non-executive roles, including at Ashtead plc, Greencoat UK Wind plc, and LGT Capital Partners Group Holding Ltd​​.
  2. Maria Bentley - Non-Executive Director: Maria Bentley, with over 30 years of experience in financial services and investment banking, joined Peel Hunt's board in 2022. She has held senior human resources roles at Goldman Sachs, UBS Investment Bank, and Nomura International. She also serves as a non-executive director and chair of remuneration at various firms including Daiwa Capital Markets Europe Limited​​.
  3. Liz Blythe - Non-Executive Director: Liz Blythe, who joined the board in 2020, has a background in audit and finance, having served as Chief Internal Auditor at Skipton Building Society and Finance Director at Homeloan Management Limited. She also holds roles as a non-executive director at other firms including Together Personal Finance​​.
  4. Richard Brearley - Non-Executive Director: Richard Brearley, an Independent Non-Executive Director since 2020, has a strong background in compliance. He has held senior roles at Ninety One, Macquarie, and Investec plc, covering a range of markets and business areas​​.
  5. Darren Carter - Non-Executive Director: Darren Carter has been with Peel Hunt since 2004, bringing over 30 years of equity markets experience. He has held senior positions at D. E. Shaw Securities International and KBC Financial Products, and is involved with other financial firms like Praetura Ventures and Praetura Debt​​.
  6. Steven Fine - Chief Executive: Steven Fine has been with Peel Hunt since 2006 and played a pivotal role in the management buy-out from KBC Bank in 2010. He has extensive experience in equity, convertible, and derivatives operations, and is a non-executive director for the Quoted Companies Alliance​​.
  7. Sunil Dhall - Chief Financial & Operating Officer: Sunil Dhall has been with Peel Hunt since 2010 and previously held senior roles at KBC Financial Products and Credit Suisse. He is active in initiatives to improve socio-economic diversity in UK financial services and holds a degree in Engineering, Economics, and Management from Keble College, Oxford​​.

These individuals contribute to Peel Hunt's strategic direction and operations with their diverse experiences and specialised expertise, underscoring the firm's commitment to leadership and excellence in the financial sector.

Executive boardEdit

  1. Steven Fine - Chief Executive:
  2. Sunil Dhall - Chief Financial & Operating Officer:
  3. Fatima Badini - HR Director: Fatima Badini brings over 25 years of experience in senior HR and office management roles across various industries including financial services, US law firms, and insurance.
  4. Alex Carter - Head of Equities: Alex Carter became Head of Equities in 2017, after joining Peel Hunt as Head of Sales in 2009.
  5. Andrew Chapman - Head of Investment Banking: Andrew Chapman has been with Peel Hunt since 2010, previously working at Citi, Hoare Govett, and having over 35 years of Investment Banking experience.
  6. Suzanne Clark - Chief Internal Auditor: Suzanne Clark joined Peel Hunt as Chief of Internal Audit in 2021 with over 25 years of experience in internal auditing across financial services.
  7. David Curran - Chief Risk Officer: David Curran joined Peel Hunt in 2005 and was appointed Chief Risk Officer in June 2021.
  8. Charles Hall - Head of Research: Charles Hall joined Peel Hunt as Head of Research in October 2008.
  9. Piya Khanna - Chief Technology Officer: Piya Khanna joined Peel Hunt as Chief Technology Officer in October 2023.
  10. Michael Lee - General Counsel: Michael Lee joined Peel Hunt as General Counsel in January 2022.
  11. Iain Morgan - Head of Execution Services: Iain Morgan joined Peel Hunt’s Trading department in 2002 and became Head of Market Making in 2005.
  12. Graham Smith - Finance Director: Graham Smith has been the Finance Director at Peel Hunt since 2012.

Management committeeEdit

  1. Hayden Ballard - Head of Sales: Hayden Ballard, Head of Sales at Peel Hunt, has been with the firm for over 12 years, contributing significantly in various departments. He also spent two years in New York setting up Peel Hunt’s US office. He joined the firm right after achieving a 1st class degree in Modern History from Bristol University.
  2. James Cooper - Head of IT Development: Information regarding James Cooper's background and tenure is not readily available.
  3. Rachelle Cornel - Director of Marketing & Communications: Rachelle Cornel has been serving as the Director of Marketing & Communications at Peel Hunt. She joined the team with an extensive background in marketing and communications, though specific details about her previous roles or educational background are not provided.
  4. Jon Gerty - Head of Group Compliance: Details about Jon Gerty, including his background and tenure, are not immediately available.
  5. James Hipkiss - CEO, Peel Hunt International: James Hipkiss's specific background information and tenure as the CEO of Peel Hunt International are not specified in the available resources.
  6. Clyde Lewis - Deputy Head of Research: Clyde Lewis's role as Deputy Head of Research at Peel Hunt is acknowledged, but further details about his career and educational background are not provided.
  7. Billy Neve - Head of Management & Financial Reporting: Information on Billy Neve, including his career history and academic qualifications, is not explicitly detailed.
  8. Matt Reali - Head of Sales Trading: Matt Reali's background and experiences leading up to his role as Head of Sales Trading at Peel Hunt are not detailed in the available sources.
  9. James Schofield - Director of Operations: James Schofield's tenure and professional background as the Director of Operations at Peel Hunt are not specified in the sources.
  10. Rob Terry - Head of Market Making: Detailed information regarding Rob Terry's career or educational background leading to his position as Head of Market Making at Peel Hunt is not available.
  11. James Webb - Deputy Head of Execution Services: Specific information about James Webb's career and academic background is not provided.
  12. Dan Webster - Deputy Head of Investment Banking: Dan Webster's professional background and experiences as Deputy Head of Investment Banking at Peel Hunt are not detailed in the sources.
  13. Hester White - Director of Corporate Strategy: Information regarding Hester White, including her tenure and professional experiences leading up to her current role, is not readily available.

What's the company's TAM, SAM and SOM in terms of definition and figures?Edit

Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) are metrics used to estimate the market potential for a business or product. However, for a company like Peel Hunt LLP, which operates in the investment banking and financial services sector, these terms are less frequently used or defined with specific figures, as their market potential is largely determined by the breadth of financial services they offer and the size of the UK mid and small-cap market segments they target.

  1. TAM (Total Addressable Market): The total market demand for a product or service. For Peel Hunt, this would theoretically encompass the entire UK financial services market.
  2. SAM (Serviceable Available Market): The segment of the TAM within a firm's reach. For Peel Hunt, this would be the UK mid and small-cap sectors that they specialise in.
  3. SOM (Serviceable Obtainable Market): The portion of SAM that a company can capture. This depends on Peel Hunt's market share and competitive position in the UK financial services sector.

Specific figures for Peel Hunt's TAM, SAM, and SOM would require detailed market analysis and internal data, which are typically not publicly available for such specialised service sectors.

Who are the company's main peers and how are they similar and different to each other?Edit

Peel Hunt LLP's main peers in the investment banking and financial services sector are other firms specialising in mid and small-cap markets in the UK. These would include companies like Numis Corporation, Panmure Gordon, and Shore Capital. Similarities:

  • All these firms offer similar services such as equity research, corporate broking, trading, and advisory services.
  • They focus on the UK market, particularly targeting mid and small-cap companies.

Differences:

  • Peel Hunt distinguishes itself through its unique client-focused approach and deep sector expertise.
  • The firm's emphasis on building long-term client relationships and its specialised focus on the UK mid and small-cap sector set it apart from its peers.
  • Additionally, Peel Hunt's strategic priorities, like expanding its investment banking capabilities and leveraging technology, contribute to its distinct positioning in the market.
This table illustrates the differences and similarities between Peel Hunt LLP and its peers (such as Numis Corporation, Panmure Gordon, and Shore Capital):
Feature/Company Peel Hunt LLP Numis Corporation Panmure Gordon Shore Capital Investec Jefferies Group LLC Stifel Financial Corp. Canaccord Genuity Group HSBC Holdings plc Barclays Investment Bank JP Morgan Cazenove Goldman Sachs Group
Equity Research
Corporate Broking
Trading Services
Advisory Services
UK Market Focus
Mid and Small-Cap Focus
Client-Focused Approach ✓/✗ ✓/✗ ✓/✗
Deep Sector Expertise ✓/✗ ✓/✗ ✓/✗
Investment Banking Expansion ✓/✗ ✓/✗ ✓/✗
Technology Emphasis ✓/✗ ✓/✗ ✓/✗

✓ = Feature is present ✗ = Feature may vary or be less emphasised

This table highlights that while these firms share a core set of services and market focus, differences emerge in their approach, emphasis on expansion, and technology integration. Peel Hunt, for example, is particularly known for its client-focused approach and emphasis on technology.

FinancialsEdit

The company in its current form (i.e. Peel Hunt LLP) was incorporated on 11th August 2010.[2] However, the company began operations in 1988, via the corporate entity Peel Hunt Holdings Limited (previously KBC Peel Hunt Limited).[3] On 10th December 2010, the business and assets of Peel Hunt Holdings Limited was transferred to Peel Hunt LLP following the management buyout from its former ultimate parent company, KBC Bank NV, on 26th November 2010.[4]


Year 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70
Period end date 23/03/1990 1/04/1991 3/04/1992 16/04/1993 22/04/1994 21/04/1995 19/04/1996 18/04/1997 17/04/1998 16/04/1999 31/03/2000 31/03/2001 31/12/2001 31/12/2002 31/12/2003 31/12/2004 31/12/2005 31/12/2006 31/12/2007 31/12/2008 31/12/2009 31/03/2011 31/03/2012 31/03/2013 31/03/2014 31/03/2015 31/03/2016 31/03/2017 31/03/2018 31/03/2019 31/03/2020 31/03/2021 31/03/2022 31/03/2023 31/03/2024 31/03/2025 31/03/2026 31/03/2027 31/03/2028 31/03/2029 31/03/2030 31/03/2031 31/03/2032 31/03/2033 31/03/2034 31/03/2035 31/03/2036 31/03/2037 31/03/2038 31/03/2039 31/03/2040 31/03/2041 31/03/2042 31/03/2043 31/03/2044 31/03/2045 31/03/2046 31/03/2047 31/03/2048 31/03/2049 31/03/2050 31/03/2051 31/03/2052 31/03/2053 31/03/2054 31/03/2055 31/03/2056 31/03/2057 31/03/2058 31/03/2059
Period duration (days) 365 365 366 365 365 365 366 365 365 365 366 365 365 365 366 365 365 365 366 365 365 366 365 365 365 366 365 365 365 366 365 365 365 366 365 365 365 366 365 365 365 366 365 365 365 366 365 365 365 366 365 365 365 366 365 365 365 366 365 365 365 366 365 365 365 366 365 365 365
Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Historic Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast Forecast
Profit and loss
Revenue 1,553 1,759 2,298 2,733 4,753 4,754 4,974 10,268 10,741 11,725 40,261 35,946 16,438 18,522 25,359 43,216 53,252 55,249 57,809 36,392 66,768 32,005 39,606 32,189 58,178 46,319 64,614 70,434 89,795 68,560 95,596 196,785 131,022 82,337
Administrative expenses (53,829) (76,219) (82,377)
Profit from operations 142,956 54,803 (40)
Finance income 30 15 692
Finance expense (824) (1,335) (2,320)
Other income 330 58 180
Profit for the year before members' remuneration and profit share 142,492 53,541 (1,488)
Members' remuneration charged as an expense (20,118) (9,908) 0
Total comprehensive income for the year available for discretionary division among members 122,374 43,633 (1,488)
Balance sheet
Assets
Non-current assets
Property, plant and equipment 9,687 9,305 8,092
Intangible assets 87 62 1,152
Right-of-use assets 19,508 17,418 15,889
Deferred tax asset 273
Total non-current assets 29,282 26,785 25,406
Current assets
Securities held for trading 47,296 50,341 54,144
Market and client debtors 531,178 559,485 471,504
Trade and other debtors 13,460 21,857 15,546
Amounts due from members 62
Cash and cash equivalents 101,859 69,916 27,410
Total current assets 693,855 701,599 568,604
Liabilities
Current liabilities
Securities held for trading (33,727) (32,705) (32,062)
Market and client creditors (464,796) (505,475) (421,953)
Amounts due to members (113,448) (21,836) 0
Trade and other creditors (13,933) (26,658) (4,214)
Loans and borrowings 0 (15,000) (6,000)
Lease liabilities (2,867)
Provisions (431) (540) (576)
Total current liabilities
Net current assets (626,335) (602,214) (467,672)
Non-current liabilities 67,520 99,385 100,932
Lease liabiliites (13,933) (22,330) (18,192)
Loans and borrowings 0 (15,000) (15,000)
Total non-current liabilities (21,462) (37,330) (33,192)
Net assets 75,340 88,840 93,146
Cash flow
Net cash (used in) / generated from operations 5,476 79,303 (76,625) (30,899)
Cash flow from investing activities
Purchase of tangible assets (750) (9,470) (1,345) (511)
Purchase of intangible assets (95) (16) (6) (1,087)
Disposal of investments not held for trading 0
Net cash used in investing activities (845) (9,486) (1,351) (1,598)
Cash flow from financing activities
Capital introduced 15,000 0 13,500 0
(Decrease)/increase in borrowings 7,500 (7,500) 30,000 (6,000)
Lease Liability payments (1,101) (905) 0 (3,117)
Interest paid (133) (253) (467) (1,382)
Net cash (used in) / generated from financing activities 21,266 (8,658) 43,033 (16,812)
Net (decrease) / increase in cash and cash equivalents 25,897 61,158 (31,943) (49,309)
Cash and cash equivalents at beginning of the period 14,803 40,701 101,859 76,719
Cash and cash equivalents at end of the the period 40,700 101,859 69,916 76,719
Other information
Research payments and execution commission
Execution services revenue
Investment banking revenue
Key metrics
Cost of goods sold as a proportion of revenue (%) N/A N/A
Operating expenses as a proportion of revenue (%) 27.35% 58.17%
Tax rate (%) N/A N/A
Depreciation and amortisation rate (%)
Fixed Capital Investment (FCInv) as a proportion of revenue (%)
Working Capital Investment (WCInv) as a proportion of revenue (%)
Net borrowing as a proportion of revenue (%)
Interest expense as a proportion of revenue (%)

What are the assumptions used to estimate the financial forecasts?Edit

Key inputs
Description Value Commentary
Revenue
What's the estimated current size of the total addressable market? $400,000,000,000 Here, the total addressable market (TAM) is defined as the global investment banking market, and based on a number of assumptions[Note 1], it is estimated that the size of the market as of today (6th January 2024), in terms of revenue, is $400 billion.
What is the estimated company lifespan? 50 years Currently, Peel Hunt employs around 300, making the company a medium organisation (less than 10,000 employees). That said, given the company's mission, we expect the company to grow to a large organisation, and research shows that the average lifespan of a large corporation is around 50 years.[5]
What's the estimated annual growth rate of the total addressable market over the lifecycle of the company? 3% Research shows that the growth rate of the global investment banking market (i.e. the total addressable market) is similar to the growth rate of global gross domestic product, which has averaged (medium) around 3% per year in the last 20 years (2001 to 2022)[6].
What's the estimated company peak market share? 1% The Stockhub users estimate that especially given the leadership of the company, the peak market share of Peel Hunt is around 0.50%, and, therefore, suggests using the share amount here. As of 7th November 2023, Peel Hunt's current share of the market is estimated at around 0.00068%.
Which function do you want to use to estimate company revenue? Logistic Research suggests that the revenue pattern of companies is similar to the pattern produced by the logistic growth function (i.e. the revenue distribution is S-shaped)[7], so the Stockhub users suggest using that function here.
What's the estimated logistic growth rate of company revenue? 5% Another way of asking this question is this way: what is the projected rate of growth for the company's revenue following a logistic model? Based on Peel Hunt's current estimated revenue amount (i.e. £82 million) and Peel Hunt's estimated lifespan (i.e. 100 years) and Peel Hunt's estimated current stage of its lifecycle (i.e. growth stage), the Stockhub users suggest using 5% annual logistic growth rate, so that's what's used here.
Growth stages
How many main stages of growth is the company expected to go through? 4 stages Research suggests that a company typically goes through four distinct stages of cash flow growth.[8] Research also shows that incorporating those stages into the discounted cash flow model improves the quality of the model and, ultimately, the quality of the value estimation.[9]

In addition, research shows that a key way to determine the stage which a company is in is by examining the cash flow patterns of the company.[10] A summary of the economic links to cash flow patterns can be found in the appendix of this report. The Stockhub users estimate that with Peel Hunt's operating cash flows positive (+), investing cash flows negative (-) and its financing cash flows positive (+), the company is in the second stage of growth (i.e. the 'growth' stage), and, therefore, it has a total of three main stages of growth. Note, to account for one-off events, the three-year average (median) amount was used to calculate the cash flows.

What proportion of the company lifecycle is represented by growth stage 1? 30% Research suggests 30%.[11]
What proportion of the company lifecycle is represented by growth stage 2? 10% Research suggests 10%.[11]
What proportion of the company lifecycle is represented by growth stage 3? 20% Research suggests 20%.[11]
What proportion of the company lifecycle is represented by growth stage 4? 40% Research suggests 40%.[11]
Growth stage 2
Cost of goods sold as a proportion of revenue (%) 27.59% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 2)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Operating expenses as a proportion of revenue (%) 75.98% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 2)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Tax rate (%) 41.08% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 2)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Depreciation and amortisation rate (%) 5.86% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 2)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Fixed Capital Investment (FCInv) as a proportion of revenue (%) 5.78% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 2)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Working Capital Investment (WCInv) as a proportion of revenue (%) 55.99% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 2)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Net borrowing as a proportion of revenue (%) 18.25% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 2)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Interest expense as a proportion of revenue (%) 1.65% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 2)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Growth stage 3
Cost of goods sold as a proportion of revenue (%) 27.59% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 3)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Operating expenses as a proportion of revenue (%) 75.98% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 3)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Tax rate (%) 41.08% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 3)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Depreciation and amortisation rate (%) 5.86% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 3)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Fixed Capital Investment (FCInv) as a proportion of revenue (%) 5.78% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 3)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Working Capital Investment (WCInv) as a proportion of revenue (%) 55.99% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 3)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Net borrowing as a proportion of revenue (%) 18.25% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 3)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Interest expense as a proportion of revenue (%) 1.65% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 3)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Growth stage 4
Cost of goods sold as a proportion of revenue (%) 36.13% Research suggests that it's best to use a similar margin rate as the one used by peers that are in the same growth stage (i.e. growth stage 4)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Operating expenses as a proportion of revenue (%) 174.39% Research suggests that it's best to use a similar margin rate as the one used by peers that are in the same growth stage (i.e. growth stage 4)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Tax rate (%) (1.94)% Research suggests that it's best to use a similar rate as the one used by peers that are in the same growth stage (i.e. growth stage 4)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Depreciation and amortisation rate (%) 47.29% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 4)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Fixed Capital Investment (FCInv) as a proportion of revenue (%) 6.25% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 4)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Working Capital Investment (WCInv) as a proportion of revenue (%) 2.13% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 4)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Net borrowing as a proportion of revenue (%) 0% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 4)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.
Interest expense as a proportion of revenue (%) 0% Research suggests that it's best to use a similar amount as the one used by peers that are in the same growth stage (i.e. growth stage 4)[12]. Information on the peers and the calculation of the figure used here can be found in the appendix of this report.

RisksEdit

As with any investment, investing in Peel Hunt carries a level of risk. Overall, based on the Peel Hunt adjusted beta (i.e. 0.86), the degree of risk associated with an investment in Peel Hunt is 'medium'.

Here, to estimate the adjusted beta, we used the iShares MSCI World ETF to represent the market portfolio; and in terms of the time period and frequency of observations, we used the 25 available share price Peel Hunt data points. We note that the amount of available data observations for Peel Hunt is less than what's typically used in the five years of monthly data beta calculation (i.e. 25 observations vs. 60 observations), and accordingly, calculating the beta of such a company may be considered by many to be abnormal; however, for the benefit of simplifying investment comparisons and decision making, we believe that a single standardised risk measure is useful, and that the most appropriate measure is beta.

The beta value in a future period has been found to be on average closer to the mean value of 1.0, and because valuation is forward-looking, it is logical to adjust the raw beta so it more accurately predicts a future beta. In addition, here, we have assumed that for an investment to be considered 'medium' risk, it must have a beta value of between 0.50 and 1.50. Further information about the beta ratings can be found in the appendix section of this report.

The key risks

Investing in Peel Hunt LLP involves several key risks:

  1. The group’s business and financial performance have been and will continue to be affected by general economic conditions in the UK and other jurisdictions in which the group operates and adverse developments in the UK or global financial markets could have a detrimental impact on its earnings and profitability.[13]
  2. The group relies on the ability to attract, develop and retain highly skilled personnel.[13]
  3. Damage to the group’s reputation could cause harm to the group and its business prospects.[13]
  4. The group’s business is subject to inherent risks concerning liquidity, and this may have an adverse effect on the group’s business and profitability.[13]
  5. The group’s results of operations may be materially affected by market fluctuations and significant changes in the value of financial instruments.[13]
  6. A failure in the group’s operational systems may disrupt the group’s business operations, result in regulatory action against the group, and adversely impact the group’s reputation, business, financial condition and results of operations.[13]
  7. The group is exposed to risks relating to its underwriting activities.[13]
  8. The group is subject to the credit risk of counterparties.[13]
  9. The group's framework and policies for risk management may prove inadequate for the risks faced by its business and any failure to properly manage the risks it faces could cause harm to the group and its business prospects.[13]
  10. Failure to, or perceived failure to, appropriately manage potential conflicts of interest can adversely affect the group’s business and reputation.[13]
  11. The group's competitive advantage depends in part on its information technology.[13]
  12. The group faces significant and increasing competition in the financial services industry, including in changing markets.[13]
  13. The group may be unable to successfully implement its business strategies.[13]
  14. The group may be unable to protect its intellectual property effectively from misappropriation by others, including current and potential competitors.[13]
  15. The group operates in an extensive, strict, and frequently changing regulatory landscape and any changes to, or the group’s failure to comply with, any laws and regulations could adversely affect the Group’s business, financial condition and results of operation.[13]
  16. If employees of the group fail to comply with applicable laws, rules and regulations, including those associated with conduct risk or fail to adapt its business to new laws and regulations, the group could be subject to disciplinary actions, fines and loss of licences to provide its services. [13]
  17. The group is subject to risks relating to litigation, investigations, claims and potential liabilities under laws and regulations applicable to financial services.[13]
  18. Regulatory and other changes resulting from the UK’s exit from the EU could impact the group’s results.[13]
  19. The group’s collection, use, storage, disclosure, transfer and other processing of personal information could give rise to significant costs and liabilities, including as a result of governmental regulation, conflicting legal requirements or differing views of personal privacy rights, which may have a material and adverse impact on the group’s business, financial condition and results of operations.[13]
  20. The group is subject to anti-bribery and corruption and anti-money laundering laws and regulations and sanctions and embargo programmes.[13]
  21. The group may be negatively impacted by the failure of its information technology and communications systems and related operational processes, including through cyberattacks. [13]
  22. The group’s insurance coverage may not be adequate to cover all possible losses that it could suffer and its insurance costs may increase.[13]
  23. A change in taxation legislation, case law or practice of tax authorities or investigations by tax authorities in key jurisdictions could materially increase the group’s costs.[13]
  24. An active trading market for the ordinary shares may not develop or be sustained.[13]
  25. There are no guarantees that the company will pay dividends or regarding the level of any such dividends.[13]
  26. Substantial future sales of ordinary shares could impact their market price.[13]
  27. The market price of the ordinary shares may fluctuate significantly in response to a number of factors, many of which will be out of the company's control.[13]
  28. Future issues of new ordinary shares may dilute the holdings of shareholders.[13]
  29. Shareholders may be diluted as a result of future equity offerings to the extent they do not participate or are excluded from participating.[13]
  30. General risks of investing in shares traded on AIM.[13]
  31. Regulatory approvals are required to increase a shareholding in the company above certain percentage thresholds of its capital.[13]

ValuationEdit

What's the expected return of an investment in the company?Edit

The Stockhub users estimate that the expected return of an investment in the company over the next five years is 12x, which equates to an annual return of 67%. In other words, an £100,000 investment in the company is expected to return £1,302,058 in five years time. The assumptions used to estimate the return figure can be found in the table below.

Assuming that a suitable return level over five years is 67% per year or less, and Peel Hunt achieves its expected return level (of 67%), then an investment in the company is considered to be an 'suitable' one.

What are the assumptions used to estimate the return?Edit

Key inputs
Description Value Commentary
Which valuation model do you want to use? Discounted cash flow Research suggests that in terms of estimating the expected return of an investment over a period of 12-months or more, the approach that is more accurate is the discounted cash flow approach[14], so that's the approach that he Stockhub users suggest to use here; nevertheless, for completeness purposes, separately, the valuation of the company is also estimated using the using the relative valuation approach (the valuation based on the relative approach can be found in the appendix of this report).

Peel Hunt has never paid cash dividends, and on 7th February 2022, it said that it currently does not anticipate paying any cash dividends in the foreseeable future. Accordingly, the Stockhub users suggest using the free cash flow valuation method (rather than the dividend discount model).

Which financial forecasts to use? Stockhub The only available long-term forecasts (i.e. >15 years) are the ones that are supplied by the Stockhub users (the forecasts can be found in the financials section of this report), so the Stockhub users suggest using those.
Growth stage 2
Discount rate (%) 15% There are two key risk parameters for a firm that need to be estimated: its cost of equity and its cost of debt. A key way to estimate the cost of equity is by looking at the beta (or betas) of the company in question, the cost of debt from a measure of default risk (an actual or synthetic rating) and apply the market value weights for debt and equity to come up with the cost of capital.
Probability of success (%) 80% Research suggests that a suitable rate for a company in this growth stage (i.e. stage 2) is 80%.
Growth stage 3
Discount rate (%) 10% There are two key risk parameters for a firm that need to be estimated: its cost of equity and its cost of debt. A key way to estimate the cost of equity is by looking at the beta (or betas) of the company in question, the cost of debt from a measure of default risk (an actual or synthetic rating) and apply the market value weights for debt and equity to come up with the cost of capital.
Probability of success (%) 100% Research suggests that a suitable rate for a company in this growth stage (i.e. stage 3) is 100%.
Growth stage 4
Discount rate (%) 10% There are two key risk parameters for a firm that need to be estimated: its cost of equity and its cost of debt. A key way to estimate the cost of equity is by looking at the beta (or betas) of the company in question, the cost of debt from a measure of default risk (an actual or synthetic rating) and apply the market value weights for debt and equity to come up with the cost of capital.
Probability of success (%) 100% Research suggests that a suitable rate for a company in this growth stage (i.e. stage 4) is 100%.
Other key inputs
What's the current value of the company? £127.11 million The current valuation of Peel Hunt as of 27th December 2023 is £127.11 million.
Which time period do you want to use to estimate the expected return? Between now and five years time Research suggests that following a market crash, the average amount of time it takes for the price of a stock market to return to its pre-crash level (i.e. the recovery period) is at least three years.[15] Accordingly, Stockhub suggests that to account for general market cyclicity, it's best to estimate the expected return of the company between now and five years time.
Which valuation recommendation method do you want to use? Relative There's two main types of valuation recommendation methods, relative and absolute. The relative method determines the investment recommendation relative to other investments (e.g. the investment is "suitable" if it's within say the top 10% of the investment universe in terms of investment returns), whereas the absolute method determines the recommendation based on a fixed return amount (e.g. the investment is "suitable" if it returns 50% or more). Assuming sufficient data, the Stockhub users suggest using the relative method.
Which top proportion of the investment universe constitutes a "suitable" rating? 10% The proportion depends on the user's preference. That said, typically, the higher the proportion, the higher the risk associated with the investment.
Which universe of investments do you want to use? All investments If the main objective of the user is to maximise investment returns, then the Stockhub users suggest using 'all investments' as the investment universe.

Sensitivity analysisEdit

The main inputs that result in the greatest change in the expected return of the Peel Hunt investment are, in order of importance (from highest to lowest):

  1. The size of the total addressable market (the default size is $400 billion);
  2. Peel Hunt peak market share (the default share is 0.50%); and
  3. The discount rate (the default time-weighted average rate is 16.50%).

The impact of a 50% change in those main inputs to the expected return of the Peel Hunt investment is shown in the table below.

Peel Hunt investment expected return sensitivity analysis
Main input 50% worse Unchanged 50% better
The discount rate ccc% ccc% ccc%
The size of the total addressable market ccc% ccc% ccc%
Peel Hunt peak market share ccc% ccc% ccc%

ActionsEdit

To invest in Peel Hunt, click here.

To contact Peel Hunt, click here.

AppendixEdit

Relative valuation approachEdit

As noted earlier in this report, research suggests that in terms of estimating the expected return of an investment over a period of 12-months or more, the approach that is more accurate is the discounted cash flow approach, so that's the approach that Stockhub suggests using to determine the estimated value of the company (the valuation based on the discounted cash flow approach can be found in the valuation section of this report); nevertheless, for completeness purposes, separately, the valuation of the company is also estimated using the relative valuation approach.

What's the expected return of an investment in Peel Hunt using the relative valuation approach?Edit

Stockhub estimates that the expected return of an investment in Peel Hunt over the next five years is 38x, which equates to an annual return of 108%. In other words, an £100,000 investment in the company is expected to return £3,933,322 in five years time. The assumptions used to estimate the return figure can be found in the table below.

What are the assumptions used to estimate the return figure?Edit

Key inputs
Description Value Commentary
Which type of multiple do you want to use? Growth-adjusted EV/sales For the numerator, the Stockhub users believe that to account for the different financial leverage levels of its peers, it's best to use enterprise value (EV), rather than price. For the denominator, the Stockhub users believe that because it expects Peel Hunt to reinvest almost all of its revenue back into the business over the five year forecast period and therefore its earnings are expected to be abnormally low over the period, it's best to use sales. Accordingly, the Stockhub users suggest valuing its company using the EV/sales ratio. However, the Stockhub users think that to take into account the different business lifecycle stages of its peers, the most suitable valuation multiple to use is the growth-adjusted EV/sales multiple, rather than the EV/sales multiple.
In regards to the growth-adjusted EV/sales multiple, for the sales figure, which year to you want to use? Year 5 Stockhub suggests that to account for general market cyclicity, it's best to estimate the expected return of the company between now and five years time.
In regards to the growth-adjusted EV/sales multiple, for the sales growth figure, which year(s) do you want to use? Year 6, from now Stockhub suggests that for the sales growth figure, it's best to use Year 6.
In regards to the growth-adjusted EV/sales multiple, what multiple figure do you want to use? 0.18x In Stockhub's view, Peel Hunt closest peer(s) is Sova Assessment Limited.
Which financial forecasts to use? Stockhub users The only available forecasts are the ones that are supplied by the Stockhub users (the forecasts can be found in the financials section of this report), so Stockhub suggests using those.
What's the current value of the company? £127.11 million The current valuation of Peel Hunt as of 27th December 2023 is £127.11 million.
Which time period do you want to use to estimate the expected return? Between now and five years time Stockhub suggests that to account for general market cyclicity, it's best to estimate the expected return of the company between now and five years time.
Which valuation recommendation method do you want to use? Relative There's two main types of valuation recommendation methods, relative and absolute. The relative method determines the investment recommendation relative to other investments (e.g. the investment is "suitable" if it's within say the top 10% of the investment universe in terms of investment returns), whereas the absolute method determines the recommendation based on a fixed return amount (e.g. the investment is "suitable" if it returns 50% or more). Assuming sufficient data, the Stockhub users suggest using the relative method.
Which top proportion of the investment universe constitutes a "suitable" rating? 10% The proportion depends on the user's preference. That said, typically, the higher the proportion, the higher the risk associated with the investment.
Which universe of investments do you want to use? All investments If the main objective of the user is to maximise investment returns, then the Stockhub users suggest using 'all investments' as the investment universe.

Sensitivity analysisEdit

The main inputs that result in the greatest change in the expected return of the Peel Hunt investment are, in order of importance (from highest to lowest):

  1. The growth-adjusted EV/sales multiple (the default multiple 0.18);
  2. Peel Hunt Year 5 sales figure (the default figure is £48.74 million); and
  3. Peel Hunt Year 6 sales growth rate (the default rate is 98.5%).

The impact of a 50% change in those main inputs to the expected return of the Peel Hunt investment is shown in the table below.

Peel Hunt investment expected return sensitivity analysis
Main input 50% worse Unchanged 50% better
The growth-adjusted EV/sales multiple ccc% ccc% ccc%
Peel Hunt Year 5 sales figure ccc% ccc% ccc%
Peel Hunt Year 6 sales growth rate ccc% ccc% ccc%

Share capitalEdit

Number of shares currently in issue: 122,807,085.[16]

Shares not in public hands: 51.6%.[16]

Significant shareholders (above 3% shareholding)[16]
Institution Registered holding of ordinary shares % of total issued share capital
Darren Carter 10,189,585 8.3%
Gresham House Asset Management 8,093,809 6.6%
Steven Fine 5,577,351 4.5%
Peel Hunt Share Trust 5,528,728 4.5%
Unicorn Asset Management Limited 4,368,860 3.6%
Iain Morgan 4,206,689 3.4%
Canaccord Genuity Wealth (International) Limited 4,098,877 3.3%
Schroder Investment Management Limited 3,947,368 3.2%

The aggregate number of Ordinary Shares subject to lock-up in each of the second year following Admission: 33,346,520 Ordinary Shares.[16]

The aggregate number of Ordinary Shares subject to lock-up in each of the third year following Admission: 21,932,985 Ordinary Shares.[16]

The aggregate number of Ordinary Shares subject to lock-up in each of the fourth year following Admission: 10,858,688 Ordinary Shares.[16]

Last updated on 10 August 2023.

Economic links to cash flow patternsEdit

Economic links to cash flow patterns
Cash flow type Introduction Growth Shake out Mature Decline
Operating - + +/- + -
Investing - - +/- - +
Financing + + +/- - +/-

Beta risk profileEdit

Beta value Risk rating
0 to 0.50 Low
0.50 to 1.50 Medium
1.50 to 3.00 High
3.00 and above Extremely high

Peel Hunt adjusted beta calculationEdit

Date iShares MSCI World ETF unit price (USD) Peel Hunt share price (GBP) iShares MSCI World ETF unit price change (%) Peel Hunt share price change (%)
01/11/2018 86.21 N/A
01/12/2018 78.87 N/A -8.51% N/A
01/01/2019 84.96 N/A 7.72% N/A
01/02/2019 87.49 N/A 2.98% N/A
01/03/2019 88.79 N/A 1.49% N/A
01/04/2019 92.09 N/A 3.72% N/A
01/05/2019 86.76 N/A -5.79% N/A
01/06/2019 91.02 N/A 4.91% N/A
01/07/2019 91.86 N/A 0.92% N/A
01/08/2019 89.84 N/A -2.20% N/A
01/09/2019 91.78 N/A 2.16% N/A
01/10/2019 94.12 N/A 2.55% N/A
01/11/2019 96.76 N/A 2.80% N/A
01/12/2019 98.78 N/A 2.09% N/A
01/01/2020 97.73 N/A -1.06% N/A
01/02/2020 89.67 N/A -8.25% N/A
01/03/2020 77.93 N/A -13.09% N/A
01/04/2020 86.36 N/A 10.82% N/A
01/05/2020 90.70 N/A 5.03% N/A
01/06/2020 92.14 N/A 1.59% N/A
01/07/2020 96.65 N/A 4.89% N/A
01/08/2020 102.96 N/A 6.53% N/A
01/09/2020 99.52 N/A -3.34% N/A
01/10/2020 96.53 N/A -3.00% N/A
01/11/2020 108.94 N/A 12.86% N/A
01/12/2020 112.41 N/A 3.19% N/A
01/01/2021 111.49 N/A -0.82% N/A
01/02/2021 114.27 N/A 2.49% N/A
01/03/2021 118.49 N/A 3.69% N/A
01/04/2021 123.61 N/A 4.32% N/A
01/05/2021 125.60 N/A 1.61% N/A
01/06/2021 126.57 N/A 0.77% N/A
01/07/2021 128.83 N/A 1.79% N/A
01/08/2021 132.02 N/A 2.48% N/A
01/09/2021 126.46 N/A -4.21% N/A
01/10/2021 133.84 227.00 5.84% N/A
01/11/2021 131.10 210.50 -2.05% -7.27%
01/12/2021 135.32 201.00 3.22% -4.51%
01/01/2022 128.32 175.00 -5.17% -12.94%
01/02/2022 124.58 125.50 -2.91% -28.29%
01/03/2022 128.16 124.00 2.87% -1.20%
01/04/2022 117.42 121.50 -8.38% -2.02%
01/05/2022 117.94 119.00 0.44% -2.06%
01/06/2022 106.88 114.00 -9.38% -4.20%
01/07/2022 115.57 103.50 8.13% -9.21%
01/08/2022 110.28 101.00 -4.58% -2.42%
01/09/2022 99.95 88.00 -9.37% -12.87%
01/10/2022 107.42 85.50 7.47% -2.84%
01/11/2022 115.44 83.00 7.47% -2.92%
01/12/2022 109.25 85.00 -5.36% 2.41%
01/01/2023 117.01 107.00 7.10% 25.88%
01/02/2023 113.98 106.00 -2.59% -0.93%
01/03/2023 117.67 106.00 3.24% 0.00%
01/04/2023 119.79 115.00 1.80% 8.49%
01/05/2023 118.60 104.50 -0.99% -9.13%
01/06/2023 124.52 103.00 4.99% -1.44%
01/07/2023 128.54 103.00 3.23% 0.00%
01/08/2023 125.70 102.50 -2.21% -0.49%
01/09/2023 120.17 83.00 -4.40% -19.02%
01/10/2023 117.11 80.00 -2.55% -3.61%
24/10/2023 122.84 90.50 4.89% 13.13%
Peel Hunt beta and adjusted beta value
Beta Adjusted beta Comment(s)
Consistent (monthly) intervals between data points 0.79 0.86 Here, when there is no valuation event, we have assumed that the share price is the same as the previous month, and, therefore, there has been no change in the share price. For example, there was no Peel Hunt valuation event in January 2022, so we have assumed that the valuation of Peel Hunt is the same in January 2022 as the previous month of December 2020, and, therefore, the share price change in January is 0%.

Cost of equityEdit

Cost of equity (%)
Input Input value Additional information
Risk-free rate (%) 5.061% Here, the risk free rate is the US 30 year treasury bond, and is calculated as at 26th October 2023.[17] Research suggests that for the risk-free rate, it's best to use one that has the same or similar maturity to the estimated remaining lifespan of the company. Here, we have assumed that the estimated lifespan of the company is 50 years, so we have used the longest maturity, which is 30 years.
Beta 0.86 Here, to estimate the adjusted beta, we used the iShares MSCI World ETF to represent the market portfolio; and in terms of the time period and frequency of observations, we used five years of monthly data (i.e. 60 observations in total), which is supported by a study and is the most common choice. The beta value in a future period has been found to be on average closer to the mean value of 1.0, and because valuation is forward-looking, it is logical to adjust the raw beta so it more accurately predicts a future beta.
Equity risk premium (%) 7.13% Here, the equity risk premium is in relation to the global region, and is calculated as at 1st July 2023.[18] Research suggests that for the region of equity risk premium, it's best to use one that is the same or similar to the region of the beta market portfolio. Here, the region of the beta market portfolio is the world/global, so we have used the world/global region for the equity risk premium.
Cost of equity (%) 11.193% Cost of equity = Risk-free rate + Beta x Equity risk premium.

Peel Hunt Nominated Advisors ClientsEdit

Peel Hunt in the nominated advisor to 28 companies that are listed on the AIM market of the London Stock Exchange (LSE) as at 26th December 2023.[19]

Code Name Sector Location Market cap Admission date
32ID Renold Plc 6% Cum Prf Stk Gbp1 Industrial Engineering North West 621,116 28/06/2002
ABDP AB Dynamics Plc Ord 1P Industrial Engineering South West 415,112,007 22/05/2013
AET Afentra Plc Ord 10P Oil, Gas and Coal International 76,468,598 23/12/2009
AFC AFC Energy Plc Ord 0.1P Alternative Energy South East 144,326,910 24/04/2007
BOKU Boku, Inc. Cmn Shs Usd0.0001 (Di) Reg S Cat 3/144A Industrial Support Services International 409,724,748 20/11/2017
BRK Brooks Macdonald Group Plc Ord 1P Investment Banking and Brokerage Services London 299,219,466 21/03/2006
CAML Central Asia Metals Plc Ord Usd0.01 Industrial Metals and Mining International 330,339,373 30/09/2010
CFX Colefax Group Plc Ord 10P Household Goods and Home Construction London 44,814,823 24/03/2005
CRW Craneware Plc Ord 1P Health Care Providers Scotland 630,995,108 13/09/2007
CVSG CVS Group Plc Ord 0.2P Consumer Services East Anglia 1,217,571,007 18/03/2008
FDEV Frontier Developments Plc Ord 0.5P Leisure Goods South West 53,296,022 15/07/2013
GDR Genedrive Plc Ord 1.5P Pharmaceuticals and Biotechnology North West 10,394,120 04/04/2007
GMR Gaming Realms Plc Ord 10P Travel and Leisure East Anglia 102,343,242 01/08/2013
HZM Horizonte Minerals Plc Ord 20P Industrial Metals and Mining International 21,177,644 31/05/2022
IDOX Idox Plc Ord 1P Software and Computer Services Scotland 310,206,020 19/12/2000
IPX Impax Asset Management Group Plc Ord 1P Investment Banking and Brokerage Services London 741,214,737 22/03/2006
IQE IQE Plc Ord 1P Technology Hardware and Equipment Wales 230,763,498 30/09/2003
MANO Manolete Partners Plc Ord 0.4P Investment Banking and Brokerage Services London 72,206,153 14/12/2018
MPE M. P. Evans Group Plc Ord 10P Food Producers International 399,678,608 18/06/2007
NWF NWF Group Plc Ord 25P Industrial Support Services North West 111,238,607 02/06/2000
PAF Pan African Resources Plc Ord 1P Precious Metals and Mining London 319,672,865 14/09/2004
RNO Renold Plc Ord 5P Industrial Engineering North West 80,248,715 19/12/2006
SPEC Inspecs Group Plc Ord 1P Personal Goods International 85,404,081 27/02/2020
SQZ Serica Energy Plc Ord Usd0.10 Oil, Gas and Coal London 879,663,358 05/09/2006
STX Shield Therapeutics Plc Ord 1.5P Pharmaceuticals and Biotechnology Yorkshire & North East 50,442,636 26/02/2016
VANL Van Elle Holdings Plc Ord 2P Construction and Materials Midlands 40,027,850 26/10/2016
VLX Volex Plc Ord 25P Electronic and Electrical Equipment South West 591,376,248 19/03/2001
WJG Watkin Jones Plc Ord 1P Household Goods and Home Construction Wales 146,940,838 23/03/2016

Peel Hunt is ranked 12th in terms of the number of AIM-listed companies to which it is a nominated advisor as at 26th December 2023.[19]

Nominated advisor Number of clients Ranking based on clients number
Peel Hunt LLP 28 12
Numis Securities Limited 24 15
Cairn Financial Advisers LLP 21 16
SPARK Advisory Partners Limited 27 13
Cavendish Capital Markets Limited 105 1
Beaumont Cornish Limited 35 9
S P Angel Corporate Finance LLP 40 7
Singer Capital Markets Advisory LLP 52 4
Zeus Capital Limited 21 16
W H Ireland Limited 52 4
Cavendish Securities Plc 18 18
Allenby Capital Limited 55 3
Investec Bank Plc 27 13
Joh. Berenberg, Gossler & Co. KG 2 24
Strand Hanson Limited 59 2
Panmure Gordon (UK) Limited 29 11
Liberum Capital Limited 42 6
Stifel Nicolaus Europe Limited 17 19
Shore Capital & Corporate Limited 35 9
Grant Thornton UK LLP 11 20
Houlihan Lokey UK Limited 5 22
Canaccord Genuity Limited 40 7
Davy Corporate Finance 9 21
J.P. Morgan Securities plc 3 23
Sector Number of clients Ranking based on number of clients
Industrial Engineering 3 1
Oil, Gas and Coal 2 3
Alternative Energy 1 8
Industrial Support Services 2 3
Investment Banking and Brokerage Services 3 1
Industrial Metals and Mining 2 3
Household Goods and Home Construction 2 3
Health Care Providers 1 8
Consumer Services 1 8
Leisure Goods 1 8
Pharmaceuticals and Biotechnology 2 3
Travel and Leisure 1 8
Software and Computer Services 1 8
Technology Hardware and Equipment 1 8
Food Producers 1 8
Precious Metals and Mining 1 8
Personal Goods 1 8
Construction and Materials 1 8
Electronic and Electrical Equipment 1 8

Peel Hunt peer(s)Edit

Peel Hunt LLP Numis Corporation plc Panmure Gordon Shore Capital Goldman Sachs Investec Jefferies Financial Group, Inc. Stifel Financial Corp. Canaccord Genuity Group HSBC Holdings plc Barclays Investment Bank JP Morgan Cazenove Average (median)
Relative valuation data
Local currency GBP GBP GBP GBP USD USD USD USD CAD GBP GBP USD N/A
Current market capitalisation (local currency, million) 144.91 410.00 47.50 125,360 5,000 8,411 7,029 777.19 121,240 23,648 498,005 N/A
Year ago sales N/A
Current sales N/A
Sales growth rate (%) N/A
Current cash N/A
Current debt N/A
Relative valuation metrics
Enterprise value/sales
Growth-adjusted enterprise value/sales ratio
Absolute valuation data
Lifecycle growth stage Stage 2 (of 4) Stage 3 (of 4) Stage 4 (of 4) N/A Stage 2 (of 4) Stage 3 (of 4) Stage 3 (of 4) Stage 3 (of 4) Stage 2 (of 4)
Cost of goods sold as a proportion of revenue (%)
Operating expenses as a proportion of revenue (%)
Tax rate (%)
Depreciation and amortisation rate (%)
Fixed Capital Investment (FCInv) as a proportion of revenue (%)
Working Capital Investment (WCInv) as a proportion of revenue (%)
Net borrowing as a proportion of revenue (%)
Interest expense as a proportion of revenue (%)
Key metrics for different stages of the business lifecycle
Stage 1 Stage 2 Stage 3 Stage 4
Cost of goods sold as a proportion of revenue (%) N/A
Operating expenses as a proportion of revenue (%) N/A
Tax rate (%) N/A
Depreciation and amortisation rate (%) N/A
Fixed Capital Investment (FCInv) as a proportion of revenue (%) N/A
Working Capital Investment (WCInv) as a proportion of revenue (%) N/A
Net borrowing as a proportion of revenue (%) N/A
Interest expense as a proportion of revenue (%) N/A
Stage 2
Peel Hunt Goldman Sachs Barclays Bank Plc Median
Cost of goods sold as a proportion of revenue (%)
Operating expenses as a proportion of revenue (%)
Tax rate (%)
Depreciation and amortisation rate (%)
Fixed Capital Investment (FCInv) as a proportion of revenue (%)
Working Capital Investment (WCInv) as a proportion of revenue (%)
Net borrowing as a proportion of revenue (%)
Interest expense as a proportion of revenue (%)
Stage 3
Numis Corporation Investec Jefferies Financial Group, Inc. HSBC Holdings Plc Median
Cost of goods sold as a proportion of revenue (%)
Operating expenses as a proportion of revenue (%)
Tax rate (%)
Depreciation and amortisation rate (%)
Fixed Capital Investment (FCInv) as a proportion of revenue (%)
Working Capital Investment (WCInv) as a proportion of revenue (%)
Net borrowing as a proportion of revenue (%)
Interest expense as a proportion of revenue (%)
Stage 4
Blackberry Panmure Gordon Median
Cost of goods sold as a proportion of revenue (%) 36.13% 36.13%
Operating expenses as a proportion of revenue (%) 174.39% 174.39%
Tax rate (%) (1.94)% (1.94)%
Depreciation and amortisation rate (%) 47.29% 47.29%
Fixed Capital Investment (FCInv) as a proportion of revenue (%) 6.25% 6.25%
Working Capital Investment (WCInv) as a proportion of revenue (%) 2.13% 2.13%
Net borrowing as a proportion of revenue (%) 0% 0%
Interest expense as a proportion of revenue (%) 0% 0%
Numis Corporation plc
30/09/2018 30/09/2019 30/09/2020 30/09/2021 30/09/2022
Historic Historic Historic Historic Historic
Profit and loss
Revenue (£'million) 215,582 144,229
Other operating income/(loss) 8,715 (1,432)
Total income 224,297 142,797
Administrative expenses (147,859) (123,716)
Operating profit/(loss) 76,438 19,081
Finance income 1 3,906
Finance costs (2,289) (2,131)
Profit Before Tax 74,150 20,856
Taxation (16,303) (7,153)
Profit for the period 57,847 13,703
Balance sheet
Assets
Non-current assets
Property, plant and equipment 10,044 9,458
Intangible assets 558 275
Right-of-use assets 38,033 35,400
Deferred tax assets 4,006 1,354
52,641 46,487
Current assets
Trade and other receivables 467,799 403,416
Trading investments 58,972 36,071
Stock borrowing collateral 18,623 20,354
Current income tax recievable 3,171 10,792
Derivative financial instruments 629 22
Cash and cash equivalents 134,125 105,653
Total current assets 683,319 576,309
Liabilities
Non-current liabilities
Lease liabilities (39,580) (40,910)
Current liabilities
Trade and other payables (481,946) (385,720)
Trading investments (27,217) (10,340)
Lease liabilities (491) (605)
Total current liabilities (509,654) (396,665)
Net assets 186,726 185,221
Equity
Share capital 6,252 5,718
Capital redemption reserve 0 534
Other reserves 9,037 10,641
Retained earnings 171,437 168,328
Total equity 186,726 185,221
Cash flow statement
Operating activities
Cash flows generated from operating activities 77,115 7,902
Taxation paid (17,599) (7,164)
Interest received in relation to operating activities 1 436
Interest paid in relation to operating activities (1,187) 0
Net cash from/(used in) operating activities 58,330 1,174
Investing activities
Decrease in term deposits 0 0
Purchase of property, plant and equipment (8,881) (1,114)
Purchase of intangible assets (310) (19)
Proceeds on disposal of subsidiary 0 0
Proceeds/(purchase) on disposal of investments 0 0
Net cash from/(used in) investing activities (9,191) (1,133)
Financing activities
Purchase of own shares - Treasury (1,555) (8,183)
Purchase of own shares - Employee Benefit Trust (22,663) (3,385)
Cash paid in respect of lease arrangements - principal (1,811) (555)
Interest paid (1,102) (537)
Dividends paid (12,726) (15,580)
Net cash from/(used in) financing activities (39,857) (28,240)
Operating costs
Depreciation of owned plant and equipment and right-of-use assets
Amortisation of other intangible assets
Impairment of intangible assets
Marketing costs
Operating lease rentals payable – property
Office running costs – excluding operating lease rents payable
FSCS costs
Dealing and financial services costs
Data and technology costs
Legal and professional costs
Other operating costs
Staff (including contractors) costs
Total
Metrics
Cost of goods sold as a proportion of revenue (%) N/A N/A
Operating expenses as a proportion of revenue (%) 65.92% 86.64%
Tax rate (%) 21.99% 34.30%
Depreciation and amortisation rate (%)
Fixed Capital Investment (FCInv) as a proportion of revenue (%)
Working Capital Investment (WCInv) as a proportion of revenue (%)
Net borrowing as a proportion of revenue (%)
Interest expense as a proportion of revenue (%)
Panmure Gordon Group Limited
31/12/2018 31/12/2019 31/12/2020 31/12/2021 31/12/2022 30/09/2023 30/09/2024
Historic Historic Historic Historic Historic Forecast Forecast
Profit and loss
Revenue (£'000) 48,286 27,637
Cost of sales (1,882) (1,704)
Gross profit 46,404 25,933
Operating expenses (42,516) (41,648)
Total operating (loss)/profit 3,888 (15,715)
Net interest expense (119) (870)
Profit before tax 3,769 (16,585)
Tax expense 56 (127)
(Loss)/profit on ordinarily activities before taxation 3,825 (16,712)
Discontinued operations (720) 364
(Loss)/profit after taxation 3,105 (16,348)
Attributable to: equity holder of parent 3,105 (16,348)
Other comprehensive income net of income tax:
Debt instruments at fair value through other comprehensive income 2 22
Total comprehensive (loss)/profit for the year 3,107 (16,326)
Balance sheet
Assets
Non-current assets
Intangible assets 973 759
Goodwill 792 792
Property, plant and equipment 451 1,327
Deferred tax asset 174 63
Trade and other receivables 413 0
2,803 2,941
Current assets
Securities held for trading 9,135 6,405
Financial investments 3,793 2,770
Trade and other receivables 84,202 36,200
Cash and cash equivalents 8,613 4,826
105,743 50,201
Total assets 108,546 53,142
Liabilities
Current liabilities
Securities held for trading (4,098) (3,688)
Trade and other payables (77,470) (19,790)
Overdrafts 0 (15,535)
(81,568) (39,013)
Non-current liabilities
Deferred tax liability (161) (130)
Trade and other payables 0 (459)
Provisions (274) 0
(435) (589)
Total liabilities (82,003) (39,602)
Net assets 26,543 13,540
Equity
Called up share capital 420 478
Share premium 78,524 81,936
Retained earnings (52,401) (68,874)
Total equity 26,543 13,540
Cash flow statement
Cash flows from operating activities
Profit for the financial year 3,769 (16,585)
Finance income 0 (32)
Finance costs 0 902
Foreign exchange on capitalised shareholders loan 0 313
Depreciation 870 965
Amortisation 691 225
Change in operating assets (56,281) 50,800
Change in operating liabilities 44,840 (57,871)
Change in other non-cash items 384 28
Discontinued operations (720) 0
Utilisation of provision (533) (97)
Tax paid (52) (181)
Net cash from/(used in) operating activities (7,032) (21,533)
Cash flows from investing activities
Acquisition of intangible assets and property, plant and equipment (116) (616)
Interest received 0 32
Sale of financial investments 485 1,367
Net cash from/(used in) investing activities 369 783
Cash flows from financing activities
Funds raised from shareholders 100 2,950
Overdrafts 0 15,535
Interest paid 0 (672)
Interest paid on lease liabilities - (23)
Lease repayments (815) (827)
Net cash from/(used in) financing activities (715) 16,963
Net decrease in cash and cash equivalents (7,378) (3,787)
Cash and cash equivalents at the beginning of the year 15,991 8,613
Cash and cash equivalents at the end of the year 8,613 4,826
Metrics
Cost of goods sold as a proportion of revenue (%)
Operating expenses as a proportion of revenue (%)
Tax rate (%)
Depreciation and amortisation rate (%)
Fixed Capital Investment (FCInv) as a proportion of revenue (%)
Working Capital Investment (WCInv) as a proportion of revenue (%)
Net borrowing as a proportion of revenue (%)
Interest expense as a proportion of revenue (%)
Share Capital Group plc
Year 1 2 3 4 5 6[20] 7[20]
Year end date 31/12/2016 31/12/2017 31/12/2018 31/12/2019 31/12/2020 31/12/2021 31/12/2022
Historic Historic Historic Historic Historic Historic Historic
Profit and loss
Revenue 2,174 1,721
Administrative expenses (7,971) (2,495)
Profit from operations (5,797) (774)
Dividend income 2,800 0
Profit before tax (2,997) (774)
Tax credit 435 138
Profit for the year (2,562) (636)
Balance sheet
Assets
Non-current assets
Tangible assets 804 672
Investments in subsidiaries 35,784 35,784
36,588 36,456
Current assets
Debtors: amounts due within one year 5,946 5,903
Cash at bank and in hand 1,443 462
7,389 6,365
Total assets
Liabilities
Non-current liabilities
Creditors: amounts falling due after more than one year (59) (59)
Current liabilities
Creditors: amounts falling due within one year (43,062) (42,542)
Total liabilities
Net assets 856 220
Issued capital and reserves attributable to owners of the parent
Called up share capital 460 460
Share premium account 20,090 20,090
Revaluation reserve 5,596 5,596
Retained earnings (25,290) (25,926)
Total equity 856 220
Cash flow statement
Cash flows from operating activities
Profit for the year
Adjustments for:
Depreciation of property, plant and equipment
Amortisation of intangible fixed assets
Interest and other finance income
Interest and other finance expenses
Loss/(gain) on sale of property, plant and equipment
Foreign exchange gain/(loss) of revaluation of assets
Foreign exchange (loss)/gain on consolidation
Interest paid
Interest received
Income tax expense
Movements in working capital:
Decrease/(increase) in trade and other receivables
Increase in current asset investments
Increase in trade and other payables
Cash generated from operations
Income tax paid
Net cash from/(used in) operating activities
Cash flows from investing activities
Purchases of property, plant and equipment
Purchases of intangible assets
Proceeds from disposal of property, plant and equipment
Net cash from/(used in) investing activities
Cash flows from financing activities
Finance lease payments
New finance leases
Loan repayments
Loans received
Net cash from/(used in) financing activities
Metrics
Cost of goods sold as a proportion of revenue (%)
Operating expenses as a proportion of revenue (%)
Tax rate (%)
Depreciation and amortisation rate (%)
Fixed Capital Investment (FCInv) as a proportion of revenue (%)
Working Capital Investment (WCInv) as a proportion of revenue (%)
Net borrowing as a proportion of revenue (%)
Interest expense as a proportion of revenue (%)
Goldman Sachs
31/12/2018 31/12/2019 31/12/2020 31/12/2021 31/12/2022
Historic Historic Historic Historic Historic
Profit and loss
In millions, except per share amounts
Revenues
Investment banking 9,100 14,136 7,360
Investment management 6,986 8,171 9,005
Commissions and fees 3,539 3,590 4,034
Market making 15,428 15,357 18,634
Other principal transactions 4,756 11,615 654
Total non-interest revenues 39,809 52,869 39,687
Interest income 13,689 12,120 29,024
Interest expense 8,938 5,650 21,346
Net interest income 4,751 6,470 7,678
Total net revenues 44,560 59,339 47,365
Provision for credit losses 3,098 357 2,715
Operating expenses
Compensation and benefits 13,309 17,719 15,148
Transaction based 4,141 4,710 5,312
Market development 401 553 812
Communications and technology 1,347 1,573 1,808
Depreciation and amortization 1,902 2,015 2,455
Occupancy 960 981 1,026
Professional fees 1,306 1,648 1,887
Other expenses 5,617 2,739 2,716
Total operating expenses 28,983 31,938 31,164
Pre-tax earnings 12,479 27,044 13,486
Provision for taxes 3,020 5,409 2,225
Net earnings 9,459 21,635 11,261
Preferred stock dividends 544 484 497
Net earnings applicable to common shareholders 8,915 21,151 10,764
Balance sheet
$ in millions
Assets
Cash and cash equivalents 261,036 241,825
Collateralized agreements:
Securities purchased under agreements to resell (at fair value) 205,703 225,117
Securities borrowed (includes $38,578 and $39,955 at fair value) 178,771 189,041
Customer and other receivables (includes $25 and $42 at fair value) 160,673 135,448
Trading assets (at fair value and includes $40,143 and $68,208 pledged as collateral) 375,916 301,245
Investments (includes $78,201 and $83,427 at fair value, and $9,818 and $12,840 pledged as collateral) 88,719 130,629
Loans (net of allowance of $5,543 and $3,573, and includes $7,655 and $10,769 at fair value) 158,562 179,286
Other assets (includes $145 and $0 at fair value) 34,608 39,208
Total assets 1,463,988 1,441,799
Liabilities and shareholders’ equity
Deposits (includes $15,746 and $35,425 at fair value) 364,227 386,665
Collateralized financings:
Securities sold under agreements to repurchase (at fair value) 165,883 110,349
Securities loaned (includes $4,372 and $9,170 at fair value) 46,505 30,727
Other secured financings (includes $12,756 and $17,074 at fair value) 18,544 13,946
Customer and other payables 251,931 262,045
Trading liabilities (at fair value) 181,424 191,324
Unsecured short-term borrowings (includes $39,731 and $29,832 at fair value) 46,955 60,961
Unsecured long-term borrowings (includes $73,147 and $52,390 at fair value) 254,092 247,138
Other liabilities (includes $159 and $359 at fair value) 24,501 21,455
Total liabilities 1,354,062 1,324,610
Commitments, contingencies and guarantees
Shareholders’ equity
Preferred stock; aggregate liquidation preference of $10,703 and $10,703 10,703 10,703
Common stock; 917,815,030 and 906,430,314 shares issued, and 334,918,639 and 333,573,254 shares outstanding 9 9
Share-based awards 4,211 5,696
Nonvoting common stock; no shares issued and outstanding
Additional paid-in capital 56,396 59,050
Retained earnings 131,811 139,372
Accumulated other comprehensive loss (2,068) (3,010)
Stock held in treasury, at cost; 582,896,393 and 572,857,062 shares (91,136) (94,631)
Total shareholders’ equity 109,926 117,189
Total liabilities and shareholders’ equity 1,463,988 1,441,799
Cash flow statement
$ in millions
Cash flows from operating activities
Net earnings 9,459 21,635 11,261
Adjustments to reconcile net earnings to net cash provided by/(used for) operating activities
Depreciation and amortization 1,902 2,015 2,455
Deferred income taxes (833) 5 (2,412)
Share-based compensation 1,920 2,348 4,083
Gain related to extinguishment of unsecured borrowings (1)
Provision for credit losses 3,098 357 2,715
Changes in operating assets and liabilities:
Customer and other receivables and payables, net (30,895) 21,971 35,014
Collateralized transactions (excluding other secured financings), net (13,007) (70,058) (100,996)
Trading assets (33,405) 15,232 45,278
Trading liabilities 44,892 26,616 8,062
Loans held for sale, net 1,820 (5,556) 3,161
Other, net (3,485) (8,267) 87
Net cash provided by/(used for) operating activities (18,535) 6,298 8,708
Cash flows from investing activities
Purchase of property, leasehold improvements and equipment (6,309) (4,667) (3,748)
Proceeds from sales of property, leasehold improvements and equipment 2,970 3,933 2,706
Net cash used for business acquisitions (231) (2,115)
Purchase of investments (48,670) (39,912) (60,536)
Proceeds from sales and paydowns of investments 29,057 45,701 12,961
Loans (excluding loans held for sale), net (11,173) (35,520) (25,228)
Net cash used for investing activities (34,356) (30,465) (75,960)
Cash flows from financing activities
Unsecured short-term borrowings, net 7,707 2,137 321
Other secured financings (short-term), net 2,861 (1,320) (2,283)
Proceeds from issuance of other secured financings (long-term) 8,073 4,795 1,800
Repayment of other secured financings (long-term), including the current portion (4,137) (6,590) (3,407)
Purchase of Trust Preferred securities (11)
Proceeds from issuance of unsecured long-term borrowings 47,250 92,717 84,522
Repayment of unsecured long-term borrowings, including the current portion (55,040) (52,608) (42,806)
Derivative contracts with a financing element, net 1,037 1,121 1,797
Deposits, net 67,343 103,538 28,074
Preferred stock redemption (350) (2,675)
Common stock repurchased (1,928) (5,200) (3,500)
Settlement of share-based awards in satisfaction of withholding tax requirements (830) (985) (1,595)
Dividends and dividend equivalents paid on common stock, preferred stock and share-based awards (2,336) (2,725) (3,682)
Proceeds from issuance of preferred stock, net of issuance costs 349 2,172
Other financing, net 392 361 361
Net cash provided by financing activities 70,380 134,738 59,602
Effect of exchange rate changes on cash and cash equivalents 4,807 (5,377) (11,561)
Net increase/(decrease) in cash and cash equivalents 22,296 105,194 (19,211)
Cash and cash equivalents, beginning balance 133,546 155,842 261,036
Cash and cash equivalents, ending balance 155,842 261,036 241,825
Supplemental disclosures:
Cash payments for interest, net of capitalized interest 9,091 5,521 19,022
Cash payments for income taxes, net 2,754 6,195 4,555
Metrics
Cost of goods sold as a proportion of revenue (%)
Operating expenses as a proportion of revenue (%)
Tax rate (%)
Depreciation and amortisation rate (%)
Fixed Capital Investment (FCInv) as a proportion of revenue (%)
Working Capital Investment (WCInv) as a proportion of revenue (%)
Net borrowing as a proportion of revenue (%)
Interest expense as a proportion of revenue (%)
Blackberry
28/02/2019 28/02/2020 28/02/2021 28/02/2022 28/02/2023
Historic Historic Historic Historic Historic
Profit and loss
Revenue 893 718 656
Cost of sales 250 251 237
Gross margin 643 467 419
Operating expenses
Research and development 215 219 207
Selling, marketing and administration 344 297 340
Amortization 182 165 96
Impairment of goodwill 594 0 245
Impairment of long-lived assets 43 0 235
Gain on sale of property, plant and equipment, net 0 0 (6)
Debentures fair value adjustment 372 (212) (138)
Litigation settlement 0 0 165
1,750 469 1,144
Operating loss (1,107) (2) (725)
Investment income (loss), net (6) 21 5
Income (loss) before income taxes (1,113) 19 (720)
Provision for (recovery of) income taxes (9) 7 14
Net income (loss) (1,104) 12 (734)
Earnings (loss) per share
Basic (1.97) 0.02 (1.27)
Diluted (1.97) (0.31) (1.35)
Balance sheet
Assets
Current
Cash and cash equivalents 378 295
Short-term investments 334 131
Accounts receivable, net of allowance of $1 and $4, respectively 138 120
Other receivables 25 12
Income taxes receivable 9 3
Other current assets 159 182
1,043 743
Restricted cash and cash equivalents 28 27
Long-term investments 30 34
Other long-term assets 9 8
Operating lease right-of-use assets, net 50 44
Property, plant and equipment, net 41 25
Goodwill 844 595
Intangible assets, net 522 203
2,567 1,679
Liabilities
Current
Accounts payable 22 24
Accrued liabilities 157 143
Income taxes payable 11 20
Debentures 0 367
Deferred revenue, current 207 175
397 729
Deferred revenue, non-current 37 40
Operating lease liabilities 66 52
Other long-term liabilities 4 1
Long-term debentures 507 0
1,011 822
Commitments and contingencies
Shareholders' equity
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable 0 0
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares
Issued and outstanding - 582,157,203 voting common shares (February 28, 2022 - 576,227,898) 2,869 2,909
Deficit (1,294) (2,028)
Accumulated other comprehensive loss (19) (24)
1,556 857
2,567 1,679
Cash flow statement
Cash flows from operating activities
Net income (loss) (1,104) 12 (734)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Amortization 198 176 105
Stock-based compensation 44 36 34
Gain on sale of investment 0 (22) 0
Impairment of goodwill 594 0 245
Impairment of long-lived assets 43 0 235
Gain on sale of property, plant and equipment, net 0 0 (6)
Debentures fair value adjustment 372 (212) (138)
Operating leases (4) (16) (16)
Other (5) (3) (5)
Net changes in working capital items
Accounts receivable, net of allowance 29 44 18
Other receivables (11) 0 13
Income taxes receivable (4) 1 6
Other assets 55 15 (1)
Accounts payable (11) 2 2
Accrued liabilities (20) (16) (11)
Income taxes payable (15) 5 9
Deferred revenue (79) (50) (29)
Net cash provided by (used in) operating activities 82 (28) (263)
Cash flows from investing activities
Acquisition of long-term investments (5) (1) (3)
Proceeds on sale, maturity or distribution from long-term investments 0 35 0
Acquisition of property, plant and equipment (8) (8) (7)
Proceeds on sale of property, plant and equipment 0 0 17
Acquisition of intangible assets (36) (31) (34)
Acquisition of short-term investments (1,039) (916) (514)
Acquisition of restricted short-term investments (24) 0 0
Proceeds on sale or maturity of restricted short-term investments 0 24 0
Proceeds on sale or maturity of short-term investments 1,047 1,104 717
Net cash provided by (used in) investing activities (65) 207 176
Cash flows from financing activities
Issuance of common shares 19 10 6
Payment of finance lease liability (1) 0 0
Repurchase of 3.75% Debentures (610) 0 0
Issuance of 1.75% Debentures 365 0 0
Net cash provided by (used in) financing activities (227) 10 6
Effect of foreign exchange gain (loss) on cash, cash equivalents, restricted cash, and restricted cash equivalents 2 (1) (3)
Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents during the period (208) 188 (84)
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period 426 218 406
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period 218 406 322
Metrics
Cost of goods sold as a proportion of revenue (%) 28.00% 34.96% 36.13%
Operating expenses as a proportion of revenue (%) 195.97% 65.32% 174.39%
Tax rate (%) 0.81% 36.84% -1.94%
Depreciation and amortisation rate (%) 31.61% 47.29%
Fixed Capital Investment (FCInv) as a proportion of revenue (%) 4.93% 5.43% 6.25%
Working Capital Investment (WCInv) as a proportion of revenue (%) 89.97% 2.13%
Net borrowing as a proportion of revenue (%) 0% 0%
Interest expense as a proportion of revenue (%) 0% 0%
Investec
31/03/2021 31/03/2022 31/03/2023
Historic Historic Historic
Profit and loss
Interest income 1,951,209 3,397,341
Interest income calculated using the effective interest method 1,717,776 2,890,776
Other interest income 233,433 506,565
Interest expense (1,005,939) (2,101,584)
Net interest income 945,270 1,295,757
Fee and commission income 864,639 832,213
Fee and commission expense (46,423) (52,860)
Investment (loss)/income 27,974 (17,145)
Share of post-taxation profit of associates and joint venture holdings 79,556 29,149
Trading income/(loss) arising from
– customer flow 128,277 131,204
– balance sheet management and other trading activities (21,128) 57,714
Other operating income 12,190 4,386
Total operating income before expected credit loss impairment charges 1,990,355 2,280,418
Expected credit loss impairment charges (28,828) (81,089)
Operating income 1,961,527 2,199,329
Operating costs (1,233,948) (1,350,835)
Operating profit before goodwill, acquired intangibles and strategic actions 727,579 848,494
Impairment of goodwill (1,962) (890)
Amortisation of acquired intangibles (15,477) (15,160)
Amortisation of acquired intangibles of associates (9,249) (1,542)
Closure and rundown of the Hong Kong direct investments business (1,203) (450)
Operating profit 699,688 830,452
Net gain/(implementation costs) on distribution of associate to shareholders (2,427) 154,438
Financial impact of Group restructures (4,968)
Profit before taxation 697,261 979,922
Taxation on operating profit before goodwill, acquired intangibles and strategic actions (143,309) (179,704)
Taxation on acquired intangibles and strategic actions 2,422 17,213
Profit after taxation 556,374 817,431
Profit attributable to non-controlling interests (40,170) (12,566)
Earnings attributable to shareholders 516,204 804,865
Earnings attributable to ordinary shareholders 475,469 764,446
Earnings attributable to perpetual preferred securities and other Additional Tier 1 security holders 40,735 40,419
Balance sheet
Assets
Cash and balances at central banks 3,517,100 5,998,270 6,437,709
Loans and advances to banks 2,637,436 2,552,061 1,450,627
Non-sovereign and non-bank cash placements 439,841 684,983 644,065
Reverse repurchase agreements and cash collateral on securities borrowed 3,575,713 4,609,778 3,632,658
Sovereign debt securities 3,711,623 4,148,867 4,751,646
Bank debt securities 1,121,730 1,515,210 939,509
Other debt securities 1,364,235 1,229,287 1,229,392
Derivative financial instruments 1,683,214 1,590,513 1,386,134
Securities arising from trading activities 1,024,671 683,329 1,632,391
Investment portfolio 909,050 912,872 1,330,907
Loans and advances to customers 26,041,087 29,561,088 29,911,158
Own originated loans and advances to customers securitised 401,912 375,763 272,879
Other loans and advances 102,135 128,284 142,726
Other securitised assets 140,087 123,888 103,151
Interests in associated undertakings and joint venture holdings 679,157 734,434 53,703
Current taxation assets 60,325 33,653 69,322
Deferred taxation assets 246,622 259,370 258,126
Other assets 2,237,646 2,139,354 1,581,693
Property and equipment 329,972 335,420 278,561
Investment properties 832,061 820,555 722,481
Goodwill 259,805 258,404 262,632
Software 58,968 9,443 15,401
Other acquired intangible assets 12,574 44,152 41,136
Non-current assets classified as held for sale 51,783 79,229 35,761
51,438,747 58,828,207 57,183,768
Other financial instruments at fair value through profit or loss in respect of liabilities to customers 52,405 59,549 110,891
51,491,152 58,887,756 57,294,659
Liabilities
Deposits by banks 2,403,712 3,178,668 3,617,524
Derivative financial instruments 2,231,166 2,581,315 2,424,036
Other trading liabilities 326,189 275,589 202,256
Repurchase agreements and cash collateral on securities lent 1,003,312 863,285 936,564
Customer accounts (deposits) 34,449,430 40,118,412 39,555,669
Debt securities in issue 1,892,319 2,043,640 1,802,586
Liabilities arising on securitisation of own originated loans and advances 160,646 238,370 163,787
Liabilities arising on securitisation of other assets 108,281 95,885 81,609
Current taxation liabilities 78,790 41,631 83,183
Deferred taxation liabilities 40,333 19,624 26,545
Other liabilities 1,951,122 2,315,841 1,873,714
44,645,300 51,772,260 50,767,473

Liabilities to customers under investment contracts

49,798 56,475 108,370
Insurance liabilities, including unit-linked liabilities 2,607 3,074 2,521
44,697,705 51,831,809 50,878,364
Subordinated liabilities 1,480,951 1,316,191 1,084,630
46,178,656 53,148,000 51,962,994
Equity
Ordinary share capital 247 247 247
Ordinary share premium 1,517,852 1,516,024 1,208,161
Treasury shares (267,508) (318,987) (564,678)
Other reserves (788,222) (650,228) (850,742)
Retained income 3,772,628 4,069,776 4,553,011
Ordinary shareholders’ equity 4,234,997 4,616,832 4,345,999
Perpetual preference share capital and premium 174,053 174,869 136,259
Shareholders’ equity excluding non-controlling interests 4,409,050 4,791,701 4,482,258
Other Additional Tier 1 securities in issue 335,111 411,683 398,568
Non-controlling interests 568,335 536,372 450,839
– Perpetual preferred securities issued by subsidiaries 72,750
– Non-controlling interests in partially held subsidiaries 495,585 536,372 450,839
Total equity 5,312,496 5,739,756 5,331,665
Total liabilities and equity 51,491,152 58,887,756 57,294,659
Cash flow statement
Cash inflow from operating activities
Profit before taxation adjusted for non-cash, non-operating items and other required
adjustments 816,404 1,009,019
Taxation paid (152,140) (171,292)
Increase in operating assets (3,321,970) (2,710,850)
Increase in operating liabilities 5,729,246 2,342,880
Net cash inflow from operating activities 3,071,540 469,757

Cash flows from investing activities

Cash flow on acquisition of Group operations, net of cash acquired (9,720)
Cash inflow on disposal of Group operations 14,274 12
Derecognition of cash on disposal of subsidiaries (4,152)
Cash outflow on acquisition of associates and joint venture holdings (8,780)
Cash flow on disposal of associates and joint venture holdings 39,222 565
Cash flow on acquisition of property, equipment, software and other intangible assets (9,323) (30,337)
Cash flow on disposal of property, equipment, software and other intangible assets 4,324 25,487
Net cash (outflow)/inflow from investing activities 35,565 (13,993)
Cash flows from financing activities
Dividends paid to ordinary shareholders (178,418) (260,673)
Dividends paid to other equity holders (83,524) (71,268)
Acquisition of non-controlling interest 443 118
Repurchase of perpetual preference shares (77,835) (19,379)
Proceeds on issue of other Additional Tier 1 securities in issue 67,552 22,787
Repayment of other Additional Tier 1 securities in issue (15,951)
Cash flow on acquisition of treasury shares, net of related costs (71,836) (262,248)
Share buyback of ordinary share capital (36,150) (56,863)
Proceeds on subordinated liabilities raised 421,506 460,934
Repayment of subordinated liabilities (583,918) (665,648)
Lease liabilities paid (45,743) (46,493)
Net cash outflow from financing activities (587,923) (914,684)
Effects of exchange rates on cash and cash equivalents 90,928 (196,806)
Net (decrease)/increase in cash and cash equivalents 2,610,110 (655,726)
Cash and cash equivalents at the beginning of the year 6,489,630 9,099,740
Cash and cash equivalents at the end of the year 9,099,740 8,444,014

Cash and cash equivalents is defined as including:

Cash and balances at central banks 5,998,270 6,437,709
On demand loans and advances to banks 2,414,562 1,359,689
Non-sovereign and non-bank cash placements 684,983 644,065
Expected credit loss on cash and cash equivalents 1,925 2,551
Cash and cash equivalents at the end of the year 9,099,740 8,444,014
Metrics
Cost of goods sold as a proportion of revenue (%)
Operating expenses as a proportion of revenue (%)
Tax rate (%)
Depreciation and amortisation rate (%)
Fixed Capital Investment (FCInv) as a proportion of revenue (%)
Working Capital Investment (WCInv) as a proportion of revenue (%)
Net borrowing as a proportion of revenue (%)
Interest expense as a proportion of revenue (%)
Jefferies Financial Group, Inc.
30/11/2020 30/11/2021 30/11/2022
Historic Historic Historic
Profit and loss
(In thousands, $)
Revenues
Investment banking 2,501,494 4,365,699 2,807,822
Principal transactions 1,928,143 1,617,336 833,757
Commissions and other fees 822,248 896,015 925,494
Asset management fees and revenues 34,209 72,084 80,264
Interest 1,009,548 956,318 1,183,638
Other 584,805 1,038,012 1,318,288
Total revenues 6,880,447 8,945,464 7,149,263
Interest expense 1,029,926 931,638 1,170,425
Net revenues 5,850,521 8,013,826 5,978,838
Non-interest expenses
Compensation and benefits 2,944,071 3,554,760 2,589,044
Floor brokerage and clearing fees 266,592 301,860 347,805
Underwriting costs 95,636 117,572 42,067
Technology and communications 335,065 388,134 444,011
Occupancy and equipment rental 95,754 106,254 108,001
Business development 70,797 109,772 150,500
Professional services 176,280 215,761 240,978
Depreciation and amortization 158,439 157,420 172,902
Cost of sales 338,588 470,870 440,837
Other expenses 302,216 337,318 387,131
Total non-interest expenses 4,783,438 5,759,721 4,923,276
Earnings before income taxes 1,067,083 2,254,105 1,055,562
Income tax expense 298,673 576,729 273,852
Net earnings 768,410 1,677,376 781,710
Net earnings (loss) attributable to noncontrolling
interests -5,271 3,850 -2,397
Net loss attributable to redeemable noncontrolling
interests -1,558 -826 -1,342
Preferred stock dividends 5,634 6,949 8,281
Net earnings attributable to Jefferies Financial Group Inc. 769,605 1,667,403 777,168
Basic earnings per common share $                    2.68 $                                       6.29 $                    3.13
Diluted earnings per common share $                    2.65 $                                       6.13 $                    3.06
Balance sheet
ASSETS
Cash and cash equivalents 10,755,133 9,703,109
Cash and securities segregated and on deposit for regulatory
purposes or deposited with clearing and depository organizations 1,015,107 957,302
Financial instruments owned, at fair value (includes securities
pledged of $14,099,136 and $12,723,502 at November 30, 2022 and
2021, respectively) 18,024,621 18,666,296
Investments in and loans to related parties 1,587,409 1,426,817
Securities borrowed 6,409,420 5,831,148
Securities purchased under agreements to resell 7,642,484 4,546,691
Securities received as collateral, at fair value 7,289 100,362
Receivables:
Brokers, dealers and clearing organizations 2,454,918 1,792,937
Customers 1,615,822 1,225,137
Fees, interest and other 582,756 568,921
Premises and equipment 911,230 906,864
Goodwill 1,745,098 1,736,114
Other assets (includes assets pledged of $1,032,353 and $990,389 at
November 30, 2022 and 2021, respectively) 3,356,024 3,595,985
Total assets 56,107,311 51,057,683
LIABILITIES AND EQUITY
Short-term borrowings 221,863 528,392
Financial instruments sold, not yet purchased, at fair value 9,267,090 11,056,477
Securities loaned 1,525,721 1,366,025
Securities sold under agreements to repurchase 8,446,099 7,452,342
Other secured financings (includes $1,712 and $102,788 at fair value
at November 30, 2022 and 2021, respectively) 4,487,224 2,037,843
Obligation to return securities received as collateral, at fair value 7,289 100,362
Payables:
Brokers, dealers and clearing organizations 3,952,093 2,628,727
Customers 4,461,481 3,578,854
Lease liabilities 548,295 533,708
Accrued expenses and other liabilities 3,334,371 2,573,927
Long-term debt (includes $1,583,828 and $1,843,598 at fair value at
November 30, 2022 and 2021, respectively) 9,125,745 8,774,086
Total liabilities 45,377,271 40,630,743
MEZZANINE EQUITY
Redeemable noncontrolling interests 25,400 6,461
Mandatorily redeemable convertible preferred shares 125,000 125,000
EQUITY
Common shares, par value $1 per share, authorized 600,000,000
shares; 226,129,626 and 243,541,431 shares issued and outstanding,
after deducting 90,334,082 and 72,922,277 shares held in treasury 243,541 226,130
Additional paid-in capital 2,742,244 1,967,781
Accumulated other comprehensive loss -372,143 -379,419
Retained earnings 7,940,113 8,418,354
Total Jefferies Financial Group Inc. common shareholders' equity 10,553,755 10,232,846
Noncontrolling interests 25,885 62,633
Total equity 10,579,640 10,295,479
Total liabilities and equity 56,107,311 51,057,683
Cash flow statement
Cash flows from operating activities:
Net earnings 768,410 1,677,376 781,710
Adjustments to reconcile net earnings to net cash
provided by operating activities:
Depreciation and amortization 136,475 144,255 189,343
Deferred income taxes 64,667 96,890 -70,396
Share-based compensation 40,038 78,160 43,919
Bad debt expense 48,157 55,876 46,846
(Income) loss on investments in and loans to related
parties 75,177 -149,885 36,287
Distributions received on investments in related parties 63,134 110,963 82,161
Gain on sale of subsidiaries and investments in related parties                            -                                               -   -319,041
Other adjustments 320,611 -89,004 -601,303
Net change in assets and liabilities:
Securities deposited with clearing and depository organizations 751 34,237                            -  
Receivables:
Brokers, dealers and clearing organizations -666,491 -136,614 631,672
Customers 185,266 -329,026 384,097
Fees, interest and other -153,463 -28,340 200,672
Securities borrowed 714,664 520,455 548,567
Financial instruments owned -877,088 -1,314,603 -773,523
Securities purchased under agreements to resell -752,171 -2,552,607 3,047,353
Other assets 167,889 -225,916 -230,722
Payables:
Brokers, dealers and clearing organizations 294,397 2,173,266 -1,288,912
Customers 442,913 210,055 -882,576
Securities loaned 270,261 -282,403 -139,557
Financial instruments sold, not yet purchased -1,014,535 992,199 1,875,957
Securities sold under agreements to repurchase 799,794 133,423 -952,584
Lease liabilities -52,553 -64,377 -89,689
Accrued expenses and other liabilities 1,179,136 527,910 -715,432
Net cash provided by operating activities 2,055,439 1,582,290 1,804,849
Cash flows from investing activities:
Contributions to investments in and loans to related
parties -1,666,323 -2,339,447 -351,645
Capital distributions from investments and repayments of
loans from related parties 1,552,161 2,310,186 286,578
Originations and purchases of automobile loans, notes and
other receivables -813,867 -611,486 -527,929
Principal collections of automobile loans, notes and
other receivables 686,114 394,387 434,487
Net payments on premises and equipment, and other assets -176,958 -165,605 -224,301
Proceeds from sales of subsidiaries and investments in
related parties, net of expenses and cash of operations sold 179,654                                             -   333,149
Deconsolidation of asset management entity                            -                                               -   -23,107
Proceeds from sales and maturities of investments and
loan receivables 69,321 3,274 3,588
Other 4,215 -1,174 8,641
Net cash used in investing activities -165,683 -409,865 -60,539
Cash flows from financing activities:
Proceeds from short-term borrowings 1,619,820 1,005,000 3,659,098
Payments on short-term borrowings -1,368,255 -1,556,090 -3,338,000
Proceeds from issuance of long-term debt, net of
issuance costs 1,516,693 2,488,493 1,198,565
Repayment of long-term debt -1,716,276 -1,646,224 -824,894
Net proceeds from (payments on) other secured financings 218,010 1,197,231 -2,448,731
Net change in bank overdrafts -34,663 8,216 -14,569
Proceeds from contributions of noncontrolling interests 19,617 4,325 64,880
Payments on distributions to noncontrolling interests -1,694 -16,263 -2,629
Purchase of common shares for treasury -816,871 -269,400 -859,593
Dividends paid -160,940 -222,798 -280,104
Other 1,034 1,804 2,752
Net cash provided by (used in) financing activities -723,525 994,294 -2,843,225
Effect of exchange rate changes on cash, cash
equivalents and restricted cash 18,306 -3,387 -22,143
Net increase (decrease) in cash, cash equivalents and
restricted cash 1,184,537 2,163,332 -1,121,060
Cash, cash equivalents and restricted cash at beginning
of period 8,480,435 9,664,972 11,828,304
Cash, cash equivalents and restricted cash at end of
period 9,664,972 11,828,304 10,707,244
Supplemental disclosures of cash flow information
Cash paid during the period for:
Interest 1,080,368 936,272 1,164,093
Income taxes, net 25 727,126 214,066
Metrics
Cost of goods sold as a proportion of revenue (%)
Operating expenses as a proportion of revenue (%)
Tax rate (%)
Depreciation and amortisation rate (%)
Fixed Capital Investment (FCInv) as a proportion of revenue (%)
Working Capital Investment (WCInv) as a proportion of revenue (%)
Net borrowing as a proportion of revenue (%)
Interest expense as a proportion of revenue (%)
Barclays Bank Plc
31/12/2020 31/12/2021 31/12/2022
Historic Historic Historic
Profit and loss
£m £m £m
Continuing operations
Interest and similar income 6,006 5,672 11,779
Interest and similar expense (2,846) (2,599) (6,381)
Net interest income 3,160 3,073 5,398
Fee and commission income 7,417 8,581 8,171
Fee and commission expense (1,758) (1,994) (2,745)
Net fee and commission income 5,659 6,587 5,426
Net trading income 7,076 5,788 7,624
Net investment expense (121) (80) (323)
Other income 4 40 69
Total income 15,778 15,408 18,194
Staff costs (4,365) (4,456) (5,192)
Infrastructure costs (816) (1,054) (900)
Administration and general expenses (4,202) (4,375) (4,879)
Litigation and conduct (76) (374) (1,427)
Operating expenses (9,459) (10,259) (12,398)
Share of post-tax results of associates and joint ventures 7 4 3
Profit/(loss) on disposal of subsidiaries, associates and joint ventures 126 (12) 1
Profit before Impairment 6,452 5,141 5,800
Credit impairment (charges)/releases (3,377) 277 (933)
Profit before tax 3,075 5,418 4,867
Taxation (624) (830) (485)
Profit after tax 2,451 4,588 4,382
Attributable to:
Equity holders of the parent 1,774 3,957 3,650
Other equity instrument holders 677 631 732
Total equity holders of the parent 2,451 4,588 4,382
Profit after tax 2,451 4,588 4,382
Balance sheet
Assets
Cash and balances at central banks 169,085 202,142
Cash collateral and settlement balances 88,085 107,862
Loans and advances at amortised cost 145,259 182,507
Reverse repurchase agreements and other similar secured lending 3,177 725
Trading portfolio assets 146,871 133,771
Financial assets at fair value through the income statement 188,226 211,128
Derivative financial instruments 262,291 302,976
Financial assets at fair value through other comprehensive income 45,908 45,084
Investments in associates and joint ventures 24 26
Goodwill and intangible assets 1,449 1,665
Property, plant and equipment 1,248 1,379
Current tax assets 589 737
Deferred tax assets 2,981 4,583
Retirement benefit assets 3,879 4,743
Other assets 2,706 4,209
Total assets 1,061,778 1,203,537
Liabilities
Deposits at amortised cost 262,828 291,579
Cash collateral and settlement balances 79,047 96,811
Repurchase agreements and other similar secured borrowing 12,769 11,965
Debt securities in issue 48,388 60,012
Subordinated liabilities 32,185 38,253
Trading portfolio liabilities 53,291 72,460
Financial liabilities designated at fair value 251,131 272,055
Derivative financial instruments 256,523 289,206
Current tax liabilities 688 422
Deferred tax liabilities 6
Retirement benefit liabilities 246 184
Other liabilities 7,249 10,779
Provisions 1,110 858
Total liabilities 1,005,461 1,144,584
Equity
Called up share capital and share premium 2,348 2,348
Other equity instruments 9,693 10,691
Other reserves 861 (1,464)
Retained earnings 43,415 47,378
Total equity 56,317 58,953
Total liabilities and equity 1,061,778 1,203,537
Cash flow statement
Reconciliation of profit before tax to net cash flows from operating activities:
Profit before tax 3,075 5,418 4,867
Adjustment for non-cash items:
Credit impairment charges/(releases) 3,377 (277) 933
Depreciation, amortisation and impairment of property, plant, equipment and intangibles 441 683 483
Other provisions, including pensions 634 85 1,188
Net loss/(profit) on disposal of investments and property, plant and equipment (119) 12 8
Other non-cash movements including exchange rate movements (2,362) 1,968 (13,491)
Changes in operating assets and liabilities
Net (increase)/decrease in cash collateral and settlement balances 4,098 3,633 (1,078)
Net (increase)/decrease in loans and advances at amortised cost 7,142 (7,190) (30,617)
Net decrease/(increase) in reverse repurchase agreements and other similar secured lending (7,250) 5,804 2,452
Net increase in deposits at amortised cost 31,148 18,132 28,751
Net increase/(decrease) in debt securities in issue (4,113) 18,965 11,624
Net (decrease)/increase in repurchase agreements and other similar secured borrowing 8,411 2,326 (804)
Net increase in derivative financial instruments (1,604) (3,655) (8,002)
Net decrease/(increase) in trading portfolio assets (14,327) (19,207) 13,100
Net increase in trading portfolio liabilities 10,927 7,152 19,169
Net (increase)/decrease in financial assets and liabilities at fair value through the income statement 2,889 (14,960) (1,978)
Net increase in other assets (93) (2,235) (3,311)
Net increase in other liabilities 13 2,082 1,834
Corporate income tax paid (12) (1,239) (144)
Net cash from operating activities 42,275 17,497 24,984
Purchase of debt securities at amortised cost (7,890) (6,931) (20,014)
Proceeds from redemption or sale of debt securities at amortised cost 3,527 2,424 12,925
Purchase of financial assets at fair value through other comprehensive income (57,640) (44,058) (43,139)
Proceeds from sale or redemption of financial assets at fair value through other comprehensive income 53,367 47,601 42,157
Purchase of property, plant and equipment and intangibles (303) (758) (540)
Disposal of subsidiaries and associates, net of cash disposed 736 65
Other cash flows associated with investing activities 11 4
Net cash from investing activities (8,192) (1,653) (8,611)
Dividends paid and other coupon payments on equity instruments (982) (1,452) (963)
Issuance of subordinated liabilities 3,856 9,099 15,381
Redemption of subordinated liabilities (4,746) (7,241) (8,367)
Issue of shares and other equity instruments 1,134 1,072 3,134
Repurchase of shares and other equity instruments (903) (2,136)
Capital contribution 750
Vesting of employee share schemes (300) (356) (413)
Net cash from financing activities (1,941) 1,122 7,386
Effect of exchange rates on cash and cash equivalents 1,669 (4,231) 10,235
Net increase in cash and cash equivalents 33,811 12,735 33,994
Cash and cash equivalents at beginning of year 139,314 173,125 185,860
Cash and cash equivalents at end of year 173,125 185,860 219,854
Cash and cash equivalents comprise:
Cash and balances at central banks 155,902 169,085 202,142
Loans and advances to banks with original maturity less than three months 7,281 6,473 6,229
Cash collateral balances with central banks with original maturity less than three months 9,086 9,690 10,625
Treasury and other eligible bills with original maturity less than three months 856 612 858
Cash and cash equivalents at end of year 173,125 185,860 219,854
Metrics
Cost of goods sold as a proportion of revenue (%)
Operating expenses as a proportion of revenue (%)
Tax rate (%)
Depreciation and amortisation rate (%)
Fixed Capital Investment (FCInv) as a proportion of revenue (%)
Working Capital Investment (WCInv) as a proportion of revenue (%)
Net borrowing as a proportion of revenue (%)
Interest expense as a proportion of revenue (%)
HSBC Holdings Plc
31/12/20 31/12/21 31/12/22
Historic Historic Historic
Profit and loss
Net interest income ($m) 26,489 32,610
Net fee income 13,097 11,451
Other operating income 9,966 7,666
Net operating income before change in expected credit losses and other credit impairment charges 49,552 51,727
Change in expected credit losses and other credit impairment charges 928 (3,592)
Total operating expenses (34,620) (33,330)
  of which: staff expenses1 (18,742) (18,366)
Share of profit in associates and joint ventures 3,046 2,723
Profit/(loss) before tax 18,906 17,528
Tax credit/(charge) (4,213) (858)
Profit/(loss) after tax 14,693 16,670
Profit/(loss) attributable to:
  - ordinary shareholders of the parent company ('PAOS') 12,607 14,822
  - preference shareholders of the parent company 7
  - other equity holders of the parent company 1,303 1,213
  - non-controlling interests 776 635
(Increase)/decrease  in present value of in-force insurance business ('PVIF') (net of tax) (58) (264)
Impairment of goodwill and other intangible assets (net of tax) 608 531
PAOS net of PVIF and goodwill impairment 13,157 15,091
Reported significant items - Totals ($m)
Revenue (538) (3,618)
ECL
Operating expenses (2,472) (2,864)
Share of profit in associates and joint ventures                                —
Adjusted ($m)
Net operating income before change in expected credit losses and other credit impairment charges1 47,020 55,345
  of which: net interest income 24,894 32,602
  of which: net fee income 12,488 11,451
Change in expected credit losses and other credit impairment charges 754 (3,592)
Total operating expenses (30,104) (30,466)
Share of profit in associates and joint ventures 2,933 2,723
Profit/(loss) before tax 20,603 24,010
Year to date Year to date
Earnings metrics 31-Dec-21 31-Dec-22
Return on average equity (annualised) 7.1 % 8.7%
Return on average tangible equity (annualised) 8.3 % 9.9%
Earnings per share ($) 0.62 0.75
Adjusted ECL / average gross loans (annualised) (0.08)% 0.36 %
Dividends
Dividends per share - declared in respect of the period ($) 0.25 0.32
Dividends paid during the period, net of scrip ($m) 4,480 5,330
Value of scrip issued during period ($m)
Revenue significant items ($m)
Customer redress programmes 11 8
Disposals, acquisitions and investment in new businesses (2,799)
Fair value movements on financial instruments (242) (579)
Restructuring and other related costs (307) (248)
Cost significant items ($m)
Costs of structural reform
Customer redress programmes (49) 31
Disposals, acquisitions and investment in new businesses (18)
Impairment of goodwill and other intangibles (587) 4
Past service costs of guaranteed minimum pension benefits equalisation
Restructuring and other related costs (1,836) (2,881)
Settlements and provisions in connection with legal and regulatory matters
Share of profit in associates and joint ventures significant items ($m)
Impairment of goodwill
Balance sheet
Assets – reported ($m)
Cash and balances at central banks 403,018 327,002
Items in the course of collection from other banks 4,136 7,297
Hong Kong Government certificates of indebtedness 42,578 43,787
Trading assets 248,842 218,093
Financial assets designated and otherwise mandatorily measured at fair value through profit or loss 49,804 45,063
Derivatives 196,882 284,146
Loans and advances to banks 83,136 104,882
Loans and advances to customers (net) 1,045,814 924,854
Reverse repurchase agreements – non-trading 241,648 253,754
Financial investments 446,274 425,564
Prepayments, accrued income and other assets1 139,982 272,785
Current tax assets 970 1,230
Interests in associates and joint ventures 29,609 29,254
Goodwill and intangible assets 20,622 21,321
Deferred tax assets 4,624 7,498
Total assets 2,957,939 2,966,530
Liabilities – reported ($m)
Hong Kong currency notes in circulation 42,578 43,787
Deposits by banks 101,152 66,722
Customer accounts 1,710,574 1,570,303
Repurchase agreements – non-trading 126,670 127,747
Items in the course of transmission to other banks 5,214 7,864
Trading liabilities 84,904 72,353
Financial liabilities designated at fair value 145,502 127,327
Derivatives 191,064 285,764
Debt securities in issue 78,557 78,149
Accruals, deferred income and other liabilities2 123,778 247,837
Current tax liabilities 698 1,135
Liabilities under insurance contracts 112,745 114,844
Provisions 2,566 1,958
Deferred tax liabilities 4,673 2,422
Subordinated liabilities 20,487 22,290
Total liabilities 2,751,162 2,770,502
Equity – reported ($m)
Called up share capital 10,316 10,147
Share premium account 14,602 14,664
Other equity instruments 22,414 19,746
Other reserves 6,460 (9,141)
Retained earnings 144,458 152,068
Total shareholders' equity 198,250 187,484
Non-controlling interests 8,527 8,544
Total equity 206,777 196,028
Total liabilities and equity 2,957,939 2,966,530
Cash flow statement
Profit before tax 8,777 18,906 17,528
Adjustments for non-cash items:
Depreciation, amortisation and impairment 5,241 4,286 3,873
Net loss/(gain) from investing activities (541) (647)               11
Share of profits in associates and joint ventures (1,597) (3,046)         (2,723)
Loss on disposal of subsidiaries, businesses, associates and joint ventures 2,639
Change in expected credit losses gross of recoveries and other credit impairment charges 9,096 (519) 3,907
Provisions including pensions 1,164 1,063 635
Share-based payment expense 433 467 400
Other non-cash items included in profit before tax (906) 510               (1,084)
Elimination of exchange differences1 (25,749) 18,937         49,127
Changes in operating assets and liabilities
Change in net trading securities and derivatives 13,150 (9,226) 20,181
Change in loans and advances to banks and customers (14,131) (11,014)         31,799
Change in reverse repurchase agreements – non-trading 9,950 552 (23,405)
Change in financial assets designated and otherwise mandatorily measured at fair value (1,962) (4,254)           8,344
Change in other assets (19,610) 19,899            (10,771)
Change in deposits by banks and customer accounts 226,723 95,703 (91,194)
Change in repurchase agreements – non-trading (28,443) 14,769            4,344
Change in debt securities in issue (9,075) (16,936)           12,518
Change in financial liabilities designated at fair value (6,630) (11,425)             (13,647)
Change in other liabilities 20,323 (10,935) 15,978
Dividends received from associates 761 808 944
Contributions paid to defined benefit plans (495) (509)             (194)
Tax paid (4,259) (3,077)             (2,776)
Net cash from operating activities 182,220 104,312 26,434
Purchase of financial investments (496,669) (493,042)         (520,600)
Proceeds from the sale and maturity of financial investments 476,990 521,190 495,049
Net cash flows from the purchase and sale of property, plant and equipment (1,446) (1,086)             (1,285)
Net cash flows from purchase/(disposal) of customer and loan portfolios 1,362 3,059 (3,530)
Net investment in intangible assets (2,064) (2,479)             (3,125)
Net cash flow from acquisition and disposal of subsidiaries, businesses, associates and joint ventures (603) (106)             (989)
Net cash from investing activities (22,430) 27,536         (34,480)
Issue of ordinary share capital and other equity instruments 1,497 1,996              
Cancellation of shares (707)                  (2,285)
Net purchases of own shares for market-making and investment purposes (181) (1,386)               (91)
Net cash flow from change in stake of subsidiaries                           —                    (197)
Redemption of preference shares and other equity instruments (398) (3,450)               (2,266)
Subordinated loan capital issued                           —                    7,300
Subordinated loan capital repaid2 (3,538) (864)             (1,777)
Dividends paid to shareholders of the parent company and non-controlling interests (2,023) (6,383)             (6,970)
Net cash from financing activities (10,794)             (6,286)
Net increase/(decrease) in cash and cash equivalents 155,147 121,054 (14,332)
Cash and cash equivalents at 1 Jan 293,742 468,323           574,032
Exchange differences in respect of cash and cash equivalents 19,434 (15,345)            (38,029)
Cash and cash equivalents at 31 Dec3 468,323 574,032 521,671
Cash and cash equivalents comprise:
– cash and balances at central banks 304,481 403,018 327,002
– items in the course of collection from other banks 4,094 4,136 7,297
– loans and advances to banks of one month or less 51,788 55,705 72,295
– reverse repurchase agreements with banks of one month or less 65,086 76,658 68,682
– treasury bills, other bills and certificates of deposit less than three months 30,023 28,488 26,727
– cash collateral and net settlement accounts 17,194 11,241 19,445
– cash and cash equivalents held for sale4 8,087
– less: items in the course of transmission to other banks (4,343) (5,214)           (7,864)
Cash and cash equivalents at 31 Dec3 468,323 574,032 521,671
Metrics
Cost of goods sold as a proportion of revenue (%)
Operating expenses as a proportion of revenue (%)
Tax rate (%)
Depreciation and amortisation rate (%)
Fixed Capital Investment (FCInv) as a proportion of revenue (%)
Working Capital Investment (WCInv) as a proportion of revenue (%)
Net borrowing as a proportion of revenue (%)
Interest expense as a proportion of revenue (%)

References and notesEdit

  1. https://www.peelhunt.com/#:~:text=,through%20the%20evolution%20of%20business
  2. https://find-and-update.company-information.service.gov.uk/company/OC357088
  3. https://find-and-update.company-information.service.gov.uk/company/02320252
  4. https://find-and-update.company-information.service.gov.uk/company/OC357088/filing-history/MzA0OTEyNDc0MmFkaXF6a2N4/document?format=pdf&download=0
  5. Stadler, Enduring Success, 3–5.
  6. https://www.macrotrends.net/countries/WLD/world/gdp-growth-rate
  7. https://decisionanalyticsjournal.springeropen.com/articles/10.1186/2193-8636-1-2
  8. Levie J, Lichtenstein BB (2010) A terminal assessment of stages theory: Introducing a dynamic approach to entrepreneurship. Entrepreneurship: Theory & Practice 34(2): 317–350. https://doi.org/10.1111/j.1540-6520.2010.00377.x
  9. Stef Hinfelaar et al.:, 2019.
  10. Dickinson, 2010.
  11. 11.0 11.1 11.2 11.3 http://escml.umd.edu/Papers/ObsCPMT.pdf
  12. 12.00 12.01 12.02 12.03 12.04 12.05 12.06 12.07 12.08 12.09 12.10 12.11 12.12 12.13 12.14 12.15 12.16 12.17 12.18 12.19 12.20 12.21 12.22 12.23 http://people.stern.nyu.edu/adamodar/pdfiles/papers/younggrowth.pdf
  13. 13.00 13.01 13.02 13.03 13.04 13.05 13.06 13.07 13.08 13.09 13.10 13.11 13.12 13.13 13.14 13.15 13.16 13.17 13.18 13.19 13.20 13.21 13.22 13.23 13.24 13.25 13.26 13.27 13.28 13.29 13.30 https://www.peelhunt.com/media/icneklr5/admission-document.pdf
  14. Demirakos et al., 2010; Gleason et al., 2013
  15. https://www.newyorkfed.org/mediabrary/media/medialibrary/media/research/staff_reports/research_papers/9809.pdf
  16. 16.0 16.1 16.2 16.3 16.4 16.5 https://www.peelhunt.com/investors/share-capital/
  17. https://www.marketwatch.com/investing/bond/tmubmusd30y?countrycode=bx
  18. https://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/ctryprem.html
  19. 19.0 19.1 https://www.londonstockexchange.com/adviser
  20. 20.0 20.1 https://find-and-update.company-information.service.gov.uk/company/02089582/filing-history/MzM4Mzg5MDEwNmFkaXF6a2N4/document?format=pdf&download=0


Cite error: <ref> tags exist for a group named "Note", but no corresponding <references group="Note"/> tag was found